Gene Symbol | Gene ID | Gene Info |
---|---|---|
Wrnip1
|
ENSMUSG00000021400.6 | Werner helicase interacting protein 1 |
Mta3
|
ENSMUSG00000055817.11 | metastasis associated 3 |
Rcor1
|
ENSMUSG00000037896.11 | REST corepressor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr17_83732039_83732526 | Mta3 | 3118 | 0.315365 | -0.74 | 1.2e-11 | Click! |
chr17_83809429_83809789 | Mta3 | 14187 | 0.174323 | -0.60 | 4.9e-07 | Click! |
chr17_83736887_83737121 | Mta3 | 7840 | 0.247794 | -0.59 | 7.7e-07 | Click! |
chr17_83685549_83685759 | Mta3 | 20509 | 0.213339 | -0.54 | 6.9e-06 | Click! |
chr17_83780212_83780445 | Mta3 | 8593 | 0.218284 | -0.52 | 2.5e-05 | Click! |
chr12_111029168_111029722 | Rcor1 | 9906 | 0.119660 | -0.69 | 8.7e-10 | Click! |
chr12_111029750_111029926 | Rcor1 | 9513 | 0.120561 | -0.69 | 1.2e-09 | Click! |
chr12_111037860_111038011 | Rcor1 | 1416 | 0.309384 | 0.39 | 1.9e-03 | Click! |
chr12_111035125_111035919 | Rcor1 | 3829 | 0.152428 | -0.39 | 2.0e-03 | Click! |
chr12_111038099_111038250 | Rcor1 | 1177 | 0.368797 | 0.39 | 2.3e-03 | Click! |
chr13_32795325_32795476 | Wrnip1 | 6638 | 0.142788 | -0.27 | 4.0e-02 | Click! |
chr13_32806276_32806888 | Wrnip1 | 368 | 0.811186 | 0.17 | 2.0e-01 | Click! |
chr13_32805143_32805294 | Wrnip1 | 1732 | 0.249876 | 0.13 | 3.4e-01 | Click! |
chr13_32801335_32801777 | Wrnip1 | 482 | 0.671360 | -0.00 | 9.9e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_12636042_12637507 | 100.05 |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
15934 |
0.17 |
chrX_170674573_170675954 | 73.95 |
Asmt |
acetylserotonin O-methyltransferase |
2619 |
0.41 |
chr12_75176309_75177605 | 66.20 |
Kcnh5 |
potassium voltage-gated channel, subfamily H (eag-related), member 5 |
375 |
0.92 |
chr14_28508967_28511864 | 64.18 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chr7_45785390_45787192 | 54.90 |
Lmtk3 |
lemur tyrosine kinase 3 |
266 |
0.77 |
chr7_44441951_44442938 | 52.65 |
Lrrc4b |
leucine rich repeat containing 4B |
41 |
0.93 |
chr7_3390544_3391386 | 52.23 |
Cacng8 |
calcium channel, voltage-dependent, gamma subunit 8 |
282 |
0.73 |
chr6_93911862_93913573 | 52.09 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr1_158362036_158363261 | 51.32 |
Astn1 |
astrotactin 1 |
98 |
0.97 |
chr7_43489310_43490670 | 50.22 |
Iglon5 |
IgLON family member 5 |
85 |
0.92 |
chr2_178141581_178143125 | 49.37 |
Phactr3 |
phosphatase and actin regulator 3 |
420 |
0.88 |
chr3_31309226_31310664 | 46.77 |
Slc7a14 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 14 |
433 |
0.72 |
chr15_98003545_98005314 | 46.16 |
Col2a1 |
collagen, type II, alpha 1 |
62 |
0.97 |
chr7_44428104_44428935 | 45.78 |
Lrrc4b |
leucine rich repeat containing 4B |
499 |
0.58 |
chr3_8509825_8511666 | 44.98 |
Stmn2 |
stathmin-like 2 |
1159 |
0.54 |
chr19_6418703_6419936 | 44.04 |
Nrxn2 |
neurexin II |
554 |
0.44 |
chr12_117153278_117156362 | 42.90 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr6_127768524_127769705 | 42.90 |
Prmt8 |
protein arginine N-methyltransferase 8 |
358 |
0.74 |
chr5_130448513_130449808 | 42.86 |
Caln1 |
calneuron 1 |
359 |
0.91 |
chr6_114282516_114283979 | 42.66 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
457 |
0.87 |
chr11_69558887_69560206 | 42.64 |
Efnb3 |
ephrin B3 |
659 |
0.46 |
chr7_100926314_100930096 | 42.09 |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
3902 |
0.17 |
chr2_91930544_91931926 | 41.81 |
Mdk |
midkine |
453 |
0.69 |
chr3_87172358_87174678 | 41.77 |
Kirrel |
kirre like nephrin family adhesion molecule 1 |
1032 |
0.5 |
chr16_5884597_5886147 | 41.58 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
17 |
0.99 |
chr12_67221394_67222796 | 41.05 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
286 |
0.94 |
chr1_19213854_19215338 | 40.48 |
Tfap2b |
transcription factor AP-2 beta |
717 |
0.69 |
chr5_116590520_116593206 | 40.05 |
Srrm4 |
serine/arginine repetitive matrix 4 |
46 |
0.98 |
chr4_25799045_25800424 | 39.70 |
Fut9 |
fucosyltransferase 9 |
121 |
0.96 |
chr7_44428985_44430475 | 39.38 |
Lrrc4b |
leucine rich repeat containing 4B |
712 |
0.43 |
chr7_19175632_19177533 | 38.83 |
Eml2 |
echinoderm microtubule associated protein like 2 |
161 |
0.88 |
chr7_30291688_30292446 | 38.75 |
Clip3 |
CAP-GLY domain containing linker protein 3 |
109 |
0.9 |
chr10_106469534_106470969 | 38.68 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
88 |
0.97 |
chr17_55986138_55987186 | 38.37 |
Fsd1 |
fibronectin type 3 and SPRY domain-containing protein |
147 |
0.89 |
chr6_42323611_42324574 | 38.35 |
Fam131b |
family with sequence similarity 131, member B |
500 |
0.63 |
chr11_94472657_94474433 | 38.24 |
Cacna1g |
calcium channel, voltage-dependent, T type, alpha 1G subunit |
96 |
0.95 |
chrX_143518219_143519318 | 38.23 |
Pak3 |
p21 (RAC1) activated kinase 3 |
70 |
0.98 |
chr15_74563319_74564610 | 37.67 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
63 |
0.61 |
chr17_55970296_55971683 | 37.65 |
Shd |
src homology 2 domain-containing transforming protein D |
400 |
0.68 |
chr7_16129541_16131199 | 37.63 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
22 |
0.96 |
chr8_17534365_17535810 | 37.43 |
Csmd1 |
CUB and Sushi multiple domains 1 |
194 |
0.97 |
chr17_28145328_28147472 | 37.39 |
Scube3 |
signal peptide, CUB domain, EGF-like 3 |
3874 |
0.13 |
chr18_35964551_35965976 | 37.36 |
Psd2 |
pleckstrin and Sec7 domain containing 2 |
158 |
0.94 |
chr1_132541040_132543287 | 37.24 |
Cntn2 |
contactin 2 |
702 |
0.64 |
chr2_180890379_180892235 | 36.83 |
Gm14342 |
predicted gene 14342 |
1647 |
0.19 |
chr18_37143430_37144634 | 36.74 |
Pcdhac2 |
protocadherin alpha subfamily C, 2 |
529 |
0.67 |
chr8_31089411_31091663 | 36.59 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
733 |
0.65 |
chr9_106147912_106149765 | 36.25 |
D030055H07Rik |
RIKEN cDNA D030055H07 gene |
151 |
0.9 |
chr5_125532320_125533519 | 36.16 |
Tmem132b |
transmembrane protein 132B |
532 |
0.76 |
chr2_70561988_70564432 | 36.03 |
Gad1os |
glutamate decarboxylase 1, opposite strand |
147 |
0.61 |
chr9_21196536_21198489 | 35.82 |
Pde4a |
phosphodiesterase 4A, cAMP specific |
807 |
0.45 |
chr2_181155937_181157234 | 35.77 |
Eef1a2 |
eukaryotic translation elongation factor 1 alpha 2 |
429 |
0.73 |
chr3_55242295_55243824 | 35.72 |
Dclk1 |
doublecortin-like kinase 1 |
533 |
0.78 |
chr3_88206822_88208169 | 35.58 |
Gm3764 |
predicted gene 3764 |
183 |
0.86 |
chr7_44310203_44311401 | 35.50 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
549 |
0.46 |
chr16_9994378_9995594 | 35.48 |
Grin2a |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) |
63 |
0.98 |
chr1_173366699_173367980 | 35.46 |
Cadm3 |
cell adhesion molecule 3 |
294 |
0.89 |
chr2_21367263_21369086 | 35.29 |
Gpr158 |
G protein-coupled receptor 158 |
607 |
0.59 |
chr8_62951127_62952454 | 35.27 |
Spock3 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 3 |
10 |
0.98 |
chr3_94478073_94479450 | 35.27 |
Celf3 |
CUGBP, Elav-like family member 3 |
70 |
0.92 |
chr5_27048872_27050274 | 35.07 |
Dpp6 |
dipeptidylpeptidase 6 |
180 |
0.97 |
chr4_150651111_150652374 | 35.05 |
Slc45a1 |
solute carrier family 45, member 1 |
355 |
0.88 |
chr8_9770297_9772011 | 35.01 |
Fam155a |
family with sequence similarity 155, member A |
7 |
0.79 |
chr3_108410436_108412210 | 34.67 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4229 |
0.11 |
chr11_118908287_118909561 | 34.65 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
626 |
0.73 |
chr5_115429732_115430910 | 34.55 |
Msi1 |
musashi RNA-binding protein 1 |
284 |
0.71 |
chr2_32741082_32742388 | 34.53 |
Sh2d3c |
SH2 domain containing 3C |
243 |
0.72 |
chr6_55451730_55453138 | 34.53 |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
257 |
0.93 |
chr13_42709652_42710400 | 34.43 |
Phactr1 |
phosphatase and actin regulator 1 |
445 |
0.88 |
chr4_22477149_22478263 | 34.38 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
10660 |
0.16 |
chr6_18169814_18171281 | 34.36 |
Cftr |
cystic fibrosis transmembrane conductance regulator |
140 |
0.95 |
chr5_120710211_120711265 | 34.27 |
Dtx1 |
deltex 1, E3 ubiquitin ligase |
1189 |
0.31 |
chrX_150656320_150657724 | 34.25 |
Tro |
trophinin |
350 |
0.85 |
chr19_5297797_5299076 | 34.23 |
Gal3st3 |
galactose-3-O-sulfotransferase 3 |
105 |
0.9 |
chr17_45548830_45550018 | 34.18 |
Tmem151b |
transmembrane protein 151B |
253 |
0.83 |
chr1_92847884_92848981 | 34.12 |
Gm29480 |
predicted gene 29480 |
339 |
0.76 |
chr7_62376325_62378263 | 34.00 |
Magel2 |
melanoma antigen, family L, 2 |
284 |
0.9 |
chr7_4119233_4120703 | 33.84 |
Ttyh1 |
tweety family member 1 |
214 |
0.7 |
chr1_129273098_129274282 | 33.67 |
Thsd7b |
thrombospondin, type I, domain containing 7B |
205 |
0.95 |
chr5_136881600_136883223 | 33.41 |
Col26a1 |
collagen, type XXVI, alpha 1 |
332 |
0.82 |
chr4_139832357_139834219 | 33.34 |
Pax7 |
paired box 7 |
240 |
0.94 |
chr6_110645148_110646464 | 33.30 |
Gm20387 |
predicted gene 20387 |
110 |
0.67 |
chr17_37049752_37051403 | 33.26 |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor, 1 |
54 |
0.94 |
chr1_132740444_132742155 | 33.23 |
Nfasc |
neurofascin |
458 |
0.83 |
chr9_58197310_58202560 | 33.22 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr9_56795792_56797095 | 33.18 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
25 |
0.97 |
chr1_72826047_72827238 | 33.11 |
Igfbp2 |
insulin-like growth factor binding protein 2 |
1320 |
0.5 |
chr4_49844475_49845850 | 33.10 |
Grin3a |
glutamate receptor ionotropic, NMDA3A |
387 |
0.91 |
chr1_136228373_136230942 | 33.02 |
Inava |
innate immunity activator |
362 |
0.76 |
chr3_45379351_45381850 | 33.00 |
Pcdh10 |
protocadherin 10 |
2033 |
0.25 |
chr14_57132708_57133925 | 32.88 |
Gjb6 |
gap junction protein, beta 6 |
35 |
0.97 |
chr9_117871858_117873400 | 32.84 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
45 |
0.91 |
chr7_126823319_126824529 | 32.71 |
Fam57b |
family with sequence similarity 57, member B |
621 |
0.41 |
chr11_42419852_42421693 | 32.60 |
Gabrb2 |
gamma-aminobutyric acid (GABA) A receptor, subunit beta 2 |
507 |
0.88 |
chr17_93198991_93201483 | 32.54 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
302 |
0.89 |
chr6_107529463_107530739 | 32.48 |
Lrrn1 |
leucine rich repeat protein 1, neuronal |
333 |
0.91 |
chr15_87624263_87625701 | 32.45 |
Tafa5 |
TAFA chemokine like family member 5 |
248 |
0.96 |
chr17_68836792_68837954 | 32.40 |
Gm38593 |
predicted gene, 38593 |
147 |
0.62 |
chr9_45430098_45431532 | 32.34 |
4833428L15Rik |
RIKEN cDNA 4833428L15 gene |
417 |
0.52 |
chr7_40898734_40899964 | 32.25 |
Vstm2b |
V-set and transmembrane domain containing 2B |
17 |
0.93 |
chr4_140245362_140247262 | 32.24 |
Igsf21 |
immunoglobulin superfamily, member 21 |
472 |
0.85 |
chr15_87544354_87545329 | 32.16 |
Tafa5 |
TAFA chemokine like family member 5 |
542 |
0.87 |
chr15_75565940_75567228 | 32.08 |
Ly6h |
lymphocyte antigen 6 complex, locus H |
48 |
0.96 |
chr8_99415302_99416849 | 31.87 |
Cdh8 |
cadherin 8 |
244 |
0.77 |
chr11_108923092_108924343 | 31.85 |
Axin2 |
axin 2 |
536 |
0.8 |
chr7_44592789_44594513 | 31.84 |
Kcnc3 |
potassium voltage gated channel, Shaw-related subfamily, member 3 |
344 |
0.69 |
chr15_92050857_92052193 | 31.76 |
Cntn1 |
contactin 1 |
360 |
0.9 |
chr8_70119024_70120981 | 31.70 |
Ncan |
neurocan |
871 |
0.35 |
chrX_137569718_137571626 | 31.62 |
Il1rapl2 |
interleukin 1 receptor accessory protein-like 2 |
64 |
0.98 |
chr6_105676979_105678296 | 31.58 |
Cntn4 |
contactin 4 |
23 |
0.52 |
chr6_121472749_121474141 | 31.54 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
178 |
0.95 |
chr7_137309191_137310700 | 31.53 |
Ebf3 |
early B cell factor 3 |
3971 |
0.23 |
chr10_80298461_80300404 | 31.52 |
Apc2 |
APC regulator of WNT signaling pathway 2 |
341 |
0.69 |
chr13_96131908_96133176 | 31.49 |
Sv2c |
synaptic vesicle glycoprotein 2c |
35 |
0.94 |
chr16_60605121_60606481 | 31.47 |
Gm9017 |
predicted gene 9017 |
46 |
0.78 |
chr17_42315796_42317065 | 31.32 |
Ptchd4 |
patched domain containing 4 |
170 |
0.98 |
chr6_6880959_6882181 | 31.25 |
Dlx5 |
distal-less homeobox 5 |
498 |
0.71 |
chr9_46388989_46390269 | 31.14 |
Gm47141 |
predicted gene, 47141 |
7733 |
0.16 |
chr5_71095703_71096447 | 31.08 |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2 |
226 |
0.97 |
chr5_9724633_9726223 | 31.02 |
Grm3 |
glutamate receptor, metabotropic 3 |
258 |
0.93 |
chr19_22447648_22448999 | 30.98 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
91 |
0.63 |
chr7_144283851_144285174 | 30.91 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
33 |
0.99 |
chr2_85197983_85199004 | 30.79 |
Lrrc55 |
leucine rich repeat containing 55 |
1296 |
0.28 |
chr19_5097025_5098415 | 30.78 |
Cnih2 |
cornichon family AMPA receptor auxiliary protein 2 |
662 |
0.42 |
chr14_67236008_67239452 | 30.62 |
Ebf2 |
early B cell factor 2 |
3086 |
0.21 |
chr2_49619321_49620607 | 30.58 |
Kif5c |
kinesin family member 5C |
666 |
0.78 |
chr7_123982468_123983092 | 30.54 |
Hs3st4 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 4 |
89 |
0.91 |
chr8_121730928_121732115 | 30.47 |
Jph3 |
junctophilin 3 |
954 |
0.49 |
chr7_54835204_54836499 | 30.37 |
Luzp2 |
leucine zipper protein 2 |
236 |
0.94 |
chr12_80759551_80760722 | 30.29 |
Ccdc177 |
coiled-coil domain containing 177 |
551 |
0.62 |
chr13_109116105_109117683 | 30.28 |
Pde4d |
phosphodiesterase 4D, cAMP specific |
253 |
0.96 |
chr14_66344363_66345813 | 30.25 |
Stmn4 |
stathmin-like 4 |
707 |
0.65 |
chr10_90828879_90830154 | 30.18 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
50 |
0.97 |
chr15_66285652_66286618 | 30.05 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
84 |
0.93 |
chr17_46486770_46487488 | 30.04 |
Ttbk1 |
tau tubulin kinase 1 |
546 |
0.61 |
chr14_52009953_52011160 | 29.96 |
Zfp219 |
zinc finger protein 219 |
19 |
0.94 |
chr7_79052729_79053830 | 29.96 |
Gm26633 |
predicted gene, 26633 |
44 |
0.71 |
chr9_58487884_58489303 | 29.95 |
Insyn1 |
inhibitory synaptic factor 1 |
10 |
0.98 |
chr2_109677166_109678631 | 29.92 |
Bdnf |
brain derived neurotrophic factor |
866 |
0.48 |
chr16_94996546_94998023 | 29.83 |
Kcnj6 |
potassium inwardly-rectifying channel, subfamily J, member 6 |
32 |
0.99 |
chr1_72536044_72537425 | 29.65 |
Marchf4 |
membrane associated ring-CH-type finger 4 |
196 |
0.95 |
chr14_52310870_52313267 | 29.63 |
Sall2 |
spalt like transcription factor 2 |
4255 |
0.1 |
chr3_17793835_17795104 | 29.58 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
427 |
0.75 |
chr5_37821115_37822599 | 29.49 |
Msx1 |
msh homeobox 1 |
2725 |
0.28 |
chr9_107706739_107707764 | 29.46 |
Sema3f |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
1695 |
0.2 |
chr14_3412245_3413254 | 29.44 |
Gm10409 |
predicted gene 10409 |
135 |
0.93 |
chr11_120238467_120239478 | 29.38 |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
2273 |
0.16 |
chr4_148130089_148131325 | 29.37 |
Draxin |
dorsal inhibitory axon guidance protein |
9 |
0.72 |
chr17_93201490_93204144 | 29.35 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
741 |
0.65 |
chr10_33623738_33624906 | 29.28 |
Gm15939 |
predicted gene 15939 |
76 |
0.56 |
chr14_7314401_7315446 | 29.12 |
Gm3739 |
predicted gene 3739 |
126 |
0.95 |
chr5_128432188_128433399 | 29.06 |
Tmem132d |
transmembrane protein 132D |
284 |
0.89 |
chr6_83185720_83187846 | 28.98 |
Dctn1 |
dynactin 1 |
837 |
0.39 |
chr1_176274517_176275808 | 28.89 |
Pld5 |
phospholipase D family, member 5 |
112 |
0.94 |
chr2_109693096_109694906 | 28.86 |
Bdnf |
brain derived neurotrophic factor |
408 |
0.85 |
chr14_79768163_79769199 | 28.83 |
Gm9748 |
predicted gene 9748 |
1227 |
0.37 |
chr1_92849002_92850443 | 28.80 |
Mir149 |
microRNA 149 |
656 |
0.43 |
chr6_114041186_114042349 | 28.76 |
Atp2b2 |
ATPase, Ca++ transporting, plasma membrane 2 |
248 |
0.91 |
chr18_23038815_23040349 | 28.75 |
Nol4 |
nucleolar protein 4 |
496 |
0.88 |
chr8_120232089_120233564 | 28.71 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
4370 |
0.19 |
chr7_79498955_79500626 | 28.69 |
Mir9-3hg |
Mir9-3 host gene |
236 |
0.84 |
chr6_55676662_55677830 | 28.67 |
Neurod6 |
neurogenic differentiation 6 |
4017 |
0.26 |
chrX_135210129_135210918 | 28.66 |
Tceal6 |
transcription elongation factor A (SII)-like 6 |
164 |
0.93 |
chr4_101549898_101551379 | 28.65 |
Dnajc6 |
DnaJ heat shock protein family (Hsp40) member C6 |
44 |
0.98 |
chr3_89521563_89522618 | 28.64 |
Kcnn3 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
1926 |
0.28 |
chr4_125490136_125491914 | 28.59 |
Grik3 |
glutamate receptor, ionotropic, kainate 3 |
325 |
0.89 |
chr17_54297811_54299023 | 28.58 |
Slc5a7 |
solute carrier family 5 (choline transporter), member 7 |
39 |
0.98 |
chr10_36506592_36508125 | 28.57 |
Hs3st5 |
heparan sulfate (glucosamine) 3-O-sulfotransferase 5 |
49 |
0.99 |
chr1_75382045_75382883 | 28.52 |
Speg |
SPEG complex locus |
326 |
0.79 |
chr18_72349127_72350542 | 28.48 |
Dcc |
deleted in colorectal carcinoma |
1183 |
0.64 |
chr8_102783763_102785029 | 28.47 |
Cdh11 |
cadherin 11 |
1246 |
0.45 |
chr15_76519928_76521866 | 28.37 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr7_127823788_127824540 | 28.28 |
Stx4a |
syntaxin 4A (placental) |
130 |
0.74 |
chr7_99267573_99269343 | 28.23 |
Map6 |
microtubule-associated protein 6 |
52 |
0.95 |
chr15_100871055_100872065 | 28.21 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
140 |
0.96 |
chr7_96210080_96211147 | 28.19 |
Tenm4 |
teneurin transmembrane protein 4 |
24 |
0.98 |
chr12_119945587_119946924 | 28.18 |
Tmem196 |
transmembrane protein 196 |
155 |
0.95 |
chr11_103198604_103200070 | 28.16 |
Fmnl1 |
formin-like 1 |
2536 |
0.16 |
chr11_104132745_104133730 | 28.12 |
Crhr1 |
corticotropin releasing hormone receptor 1 |
382 |
0.88 |
chr17_26941428_26942351 | 28.10 |
Syngap1 |
synaptic Ras GTPase activating protein 1 homolog (rat) |
390 |
0.63 |
chr5_115431565_115432258 | 28.10 |
Msi1 |
musashi RNA-binding protein 1 |
1306 |
0.22 |
chrX_57503221_57504242 | 28.06 |
Gpr101 |
G protein-coupled receptor 101 |
26 |
0.98 |
chr18_43686487_43688415 | 28.02 |
Jakmip2 |
janus kinase and microtubule interacting protein 2 |
174 |
0.96 |
chr8_121729721_121730922 | 28.01 |
Jph3 |
junctophilin 3 |
242 |
0.9 |
chr2_165594861_165596083 | 27.93 |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
440 |
0.82 |
chr7_4690708_4691898 | 27.93 |
Brsk1 |
BR serine/threonine kinase 1 |
223 |
0.84 |
chr17_90454435_90455834 | 27.91 |
Gm10493 |
predicted gene 10493 |
245 |
0.58 |
chr1_166255711_166256817 | 27.90 |
Ildr2 |
immunoglobulin-like domain containing receptor 2 |
2071 |
0.3 |
chr14_5148637_5149909 | 27.90 |
Gm3317 |
predicted gene 3317 |
15262 |
0.11 |
chr8_94869714_94871671 | 27.88 |
Dok4 |
docking protein 4 |
512 |
0.65 |
chr2_83812374_83813987 | 27.86 |
Fam171b |
family with sequence similarity 171, member B |
544 |
0.74 |
chr5_38158478_38159481 | 27.85 |
Nsg1 |
neuron specific gene family member 1 |
52 |
0.97 |
chr3_89226055_89227441 | 27.83 |
Mtx1 |
metaxin 1 |
304 |
0.42 |
chr6_124996779_124997957 | 27.83 |
Pianp |
PILR alpha associated neural protein |
293 |
0.78 |
chrX_73063945_73064811 | 27.74 |
Pnma3 |
paraneoplastic antigen MA3 |
409 |
0.71 |
chr6_114130915_114132167 | 27.74 |
Slc6a11 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 11 |
122 |
0.97 |
chr11_102604334_102605731 | 27.73 |
Fzd2 |
frizzled class receptor 2 |
636 |
0.55 |
chr1_132880197_132881455 | 27.69 |
Lrrn2 |
leucine rich repeat protein 2, neuronal |
471 |
0.81 |
chr15_95653733_95655035 | 27.68 |
Dbx2 |
developing brain homeobox 2 |
1576 |
0.4 |
chr8_84415331_84416224 | 27.67 |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
7 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
51.7 | 155.0 | GO:0061642 | chemoattraction of axon(GO:0061642) |
48.8 | 48.8 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
46.3 | 138.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
44.3 | 265.7 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
37.1 | 111.4 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
36.3 | 181.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
35.8 | 71.6 | GO:0048880 | sensory system development(GO:0048880) |
35.8 | 107.3 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
34.9 | 104.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
34.5 | 172.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
34.4 | 103.3 | GO:0070384 | Harderian gland development(GO:0070384) |
33.7 | 67.3 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
33.5 | 67.1 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
33.5 | 100.4 | GO:0021550 | medulla oblongata development(GO:0021550) |
32.7 | 32.7 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
32.3 | 97.0 | GO:0060594 | mammary gland specification(GO:0060594) |
31.4 | 157.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
30.7 | 92.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
29.8 | 89.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
29.8 | 89.4 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
29.6 | 88.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
29.1 | 203.4 | GO:0021559 | trigeminal nerve development(GO:0021559) |
28.9 | 260.2 | GO:0071625 | vocalization behavior(GO:0071625) |
28.7 | 86.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
28.7 | 86.0 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
28.5 | 85.6 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
28.4 | 28.4 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
28.3 | 84.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
28.2 | 141.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
28.0 | 112.1 | GO:0060174 | limb bud formation(GO:0060174) |
28.0 | 83.9 | GO:0072092 | ureteric bud invasion(GO:0072092) |
27.6 | 110.5 | GO:0007412 | axon target recognition(GO:0007412) |
27.4 | 82.2 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
27.3 | 136.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
27.2 | 81.6 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
26.9 | 80.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
26.9 | 134.4 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
26.8 | 107.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
26.7 | 160.4 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
25.5 | 76.4 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
25.4 | 101.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
25.4 | 25.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
25.1 | 75.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
24.8 | 198.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
24.4 | 73.3 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
24.4 | 73.3 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
24.4 | 122.0 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
24.1 | 72.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
23.7 | 71.2 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
23.4 | 374.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
23.2 | 116.0 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
22.8 | 45.7 | GO:0021564 | vagus nerve development(GO:0021564) |
22.8 | 68.4 | GO:0021586 | pons maturation(GO:0021586) |
22.7 | 45.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
22.7 | 22.7 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
22.6 | 67.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
22.5 | 90.1 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
22.2 | 44.3 | GO:0060166 | olfactory pit development(GO:0060166) |
22.1 | 88.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
21.6 | 43.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
21.1 | 63.2 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
21.1 | 42.2 | GO:0007403 | glial cell fate determination(GO:0007403) |
21.0 | 84.0 | GO:0030035 | microspike assembly(GO:0030035) |
21.0 | 83.9 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
20.8 | 62.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
20.8 | 249.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
20.8 | 62.4 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
20.8 | 62.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
20.7 | 62.1 | GO:0033058 | directional locomotion(GO:0033058) |
20.7 | 269.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
20.7 | 62.1 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
20.6 | 164.9 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
20.5 | 122.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
20.2 | 60.7 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
19.9 | 19.9 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
19.9 | 39.8 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
19.8 | 138.8 | GO:0072044 | collecting duct development(GO:0072044) |
19.7 | 19.7 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
19.7 | 59.0 | GO:0061743 | motor learning(GO:0061743) |
19.5 | 136.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
19.3 | 38.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
19.3 | 19.3 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
19.2 | 19.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
19.2 | 57.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
19.2 | 57.5 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
19.1 | 38.2 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
19.0 | 94.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
18.8 | 37.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
18.7 | 18.7 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) nephrogenic mesenchyme development(GO:0072076) |
18.6 | 18.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
18.5 | 55.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
18.5 | 37.0 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
18.4 | 73.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
18.2 | 54.7 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
18.1 | 108.6 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
18.1 | 18.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
17.9 | 393.2 | GO:0001964 | startle response(GO:0001964) |
17.7 | 53.2 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
17.7 | 17.7 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
17.7 | 17.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
17.6 | 52.9 | GO:0002930 | trabecular meshwork development(GO:0002930) |
17.5 | 35.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
17.5 | 52.6 | GO:0071492 | cellular response to UV-A(GO:0071492) |
17.5 | 69.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
17.5 | 17.5 | GO:0072191 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
17.4 | 174.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
17.3 | 69.1 | GO:0046958 | nonassociative learning(GO:0046958) |
17.2 | 68.9 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
17.2 | 68.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
17.1 | 136.7 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
16.8 | 16.8 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
16.6 | 83.2 | GO:0035989 | tendon development(GO:0035989) |
16.6 | 16.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
16.6 | 132.6 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
16.6 | 49.7 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
16.5 | 16.5 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
16.5 | 33.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
16.3 | 49.0 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
16.3 | 32.5 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
16.3 | 16.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
16.3 | 32.5 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
16.2 | 97.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
16.2 | 873.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
16.2 | 48.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
16.1 | 32.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
16.1 | 48.3 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
16.1 | 16.1 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
16.0 | 31.9 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
15.9 | 31.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
15.7 | 31.4 | GO:2000591 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
15.6 | 78.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
15.5 | 30.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
15.3 | 46.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
15.3 | 30.5 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
15.2 | 15.2 | GO:0060278 | regulation of ovulation(GO:0060278) |
15.2 | 45.6 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
15.2 | 76.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
15.2 | 45.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
15.1 | 15.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
15.1 | 45.2 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
15.0 | 180.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
15.0 | 15.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
14.9 | 29.8 | GO:0048664 | neuron fate determination(GO:0048664) |
14.8 | 29.7 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
14.8 | 59.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
14.8 | 14.8 | GO:0060592 | mammary gland formation(GO:0060592) |
14.8 | 14.8 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
14.8 | 59.1 | GO:0043396 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
14.7 | 73.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
14.6 | 43.9 | GO:1990034 | calcium ion export from cell(GO:1990034) |
14.6 | 145.7 | GO:0060581 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
14.5 | 43.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
14.5 | 43.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
14.5 | 29.0 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
14.5 | 28.9 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
14.4 | 57.7 | GO:0045759 | negative regulation of action potential(GO:0045759) |
14.4 | 28.8 | GO:1902805 | positive regulation of synaptic vesicle transport(GO:1902805) |
14.2 | 56.7 | GO:0014028 | notochord formation(GO:0014028) |
14.1 | 42.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
14.1 | 56.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
14.1 | 56.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
14.1 | 28.1 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
14.0 | 70.2 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
13.9 | 41.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
13.9 | 13.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
13.9 | 41.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
13.8 | 69.0 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
13.8 | 13.8 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
13.6 | 40.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
13.6 | 13.6 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
13.6 | 40.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
13.5 | 81.1 | GO:0007614 | short-term memory(GO:0007614) |
13.5 | 27.0 | GO:0060424 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
13.4 | 13.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
13.3 | 26.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
13.3 | 53.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
13.3 | 26.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
13.3 | 26.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
13.1 | 65.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
13.1 | 13.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
12.9 | 38.8 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
12.9 | 103.3 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
12.9 | 38.7 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
12.9 | 51.4 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
12.8 | 64.2 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
12.8 | 38.3 | GO:0030070 | insulin processing(GO:0030070) |
12.8 | 63.8 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
12.8 | 25.5 | GO:0022038 | corpus callosum development(GO:0022038) |
12.7 | 63.6 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
12.7 | 12.7 | GO:0060359 | response to ammonium ion(GO:0060359) |
12.7 | 101.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
12.6 | 12.6 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
12.6 | 214.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
12.6 | 62.9 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
12.5 | 25.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
12.5 | 25.0 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
12.5 | 49.9 | GO:0021571 | rhombomere 5 development(GO:0021571) |
12.4 | 24.9 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
12.4 | 49.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
12.4 | 37.2 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
12.4 | 37.1 | GO:0060437 | lung growth(GO:0060437) |
12.2 | 306.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
12.2 | 73.3 | GO:0048840 | otolith development(GO:0048840) |
12.2 | 61.0 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
12.1 | 24.3 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
12.1 | 362.7 | GO:0019228 | neuronal action potential(GO:0019228) |
12.0 | 47.9 | GO:0070842 | aggresome assembly(GO:0070842) |
12.0 | 47.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
11.9 | 23.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
11.9 | 35.8 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
11.9 | 11.9 | GO:0090135 | actin filament branching(GO:0090135) |
11.8 | 223.8 | GO:0003416 | endochondral bone growth(GO:0003416) |
11.8 | 35.3 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
11.8 | 58.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
11.7 | 23.5 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
11.7 | 129.0 | GO:0060074 | synapse maturation(GO:0060074) |
11.7 | 11.7 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
11.7 | 46.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
11.7 | 11.7 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
11.6 | 116.4 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
11.6 | 11.6 | GO:0051794 | regulation of catagen(GO:0051794) |
11.6 | 23.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
11.6 | 11.6 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
11.6 | 46.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
11.6 | 34.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
11.5 | 207.9 | GO:0035136 | forelimb morphogenesis(GO:0035136) |
11.3 | 34.0 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
11.3 | 22.6 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
11.3 | 11.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
11.3 | 45.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
11.3 | 33.9 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
11.3 | 45.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
11.2 | 78.7 | GO:0008038 | neuron recognition(GO:0008038) |
11.2 | 33.7 | GO:0010996 | response to auditory stimulus(GO:0010996) |
11.2 | 22.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
11.2 | 33.7 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
11.2 | 33.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
11.2 | 11.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
11.0 | 54.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
11.0 | 791.0 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
10.8 | 10.8 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
10.8 | 10.8 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
10.8 | 10.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
10.8 | 32.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
10.8 | 194.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
10.8 | 377.4 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
10.8 | 183.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
10.8 | 107.7 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
10.8 | 32.3 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
10.7 | 75.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
10.7 | 32.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
10.7 | 74.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
10.7 | 21.4 | GO:0099612 | protein localization to axon(GO:0099612) |
10.7 | 21.3 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
10.6 | 31.9 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
10.6 | 63.8 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
10.6 | 21.2 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
10.6 | 10.6 | GO:0071873 | response to norepinephrine(GO:0071873) |
10.5 | 21.1 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
10.5 | 31.6 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
10.5 | 21.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
10.5 | 21.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
10.5 | 10.5 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
10.5 | 73.5 | GO:0035640 | exploration behavior(GO:0035640) |
10.5 | 41.9 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
10.5 | 10.5 | GO:0015744 | succinate transport(GO:0015744) |
10.5 | 31.4 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
10.4 | 31.3 | GO:0010446 | response to alkaline pH(GO:0010446) |
10.4 | 10.4 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
10.4 | 10.4 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
10.4 | 20.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
10.4 | 31.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
10.3 | 51.4 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
10.2 | 10.2 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
10.2 | 10.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
10.1 | 302.5 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
10.0 | 40.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
10.0 | 10.0 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
10.0 | 20.1 | GO:0009629 | response to gravity(GO:0009629) |
9.9 | 29.8 | GO:0015888 | thiamine transport(GO:0015888) |
9.9 | 29.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
9.9 | 29.8 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
9.9 | 29.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
9.8 | 78.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
9.8 | 29.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
9.8 | 58.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
9.7 | 9.7 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
9.7 | 48.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
9.7 | 19.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
9.6 | 38.6 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
9.6 | 38.4 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
9.6 | 28.7 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
9.6 | 9.6 | GO:0046541 | saliva secretion(GO:0046541) |
9.6 | 19.1 | GO:0070253 | somatostatin secretion(GO:0070253) |
9.5 | 28.6 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
9.5 | 28.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
9.5 | 9.5 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
9.5 | 19.0 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
9.5 | 66.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
9.4 | 9.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
9.4 | 47.2 | GO:0060068 | vagina development(GO:0060068) |
9.4 | 9.4 | GO:0032341 | aldosterone metabolic process(GO:0032341) |
9.4 | 18.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
9.4 | 28.3 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
9.4 | 75.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
9.4 | 28.2 | GO:0021794 | thalamus development(GO:0021794) |
9.4 | 56.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
9.4 | 9.4 | GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
9.3 | 18.6 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
9.3 | 9.3 | GO:0060022 | hard palate development(GO:0060022) |
9.3 | 9.3 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
9.2 | 27.6 | GO:0042551 | neuron maturation(GO:0042551) |
9.2 | 9.2 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
9.1 | 18.3 | GO:0072141 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
9.0 | 18.0 | GO:0071314 | cellular response to cocaine(GO:0071314) |
9.0 | 107.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
8.9 | 35.7 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
8.9 | 8.9 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
8.8 | 44.2 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
8.8 | 26.5 | GO:0086009 | membrane repolarization(GO:0086009) |
8.8 | 70.6 | GO:0031000 | response to caffeine(GO:0031000) |
8.8 | 26.4 | GO:0070141 | response to UV-A(GO:0070141) |
8.8 | 17.6 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
8.8 | 26.4 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
8.8 | 26.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
8.7 | 26.2 | GO:0071321 | cellular response to cGMP(GO:0071321) |
8.7 | 52.4 | GO:0021854 | hypothalamus development(GO:0021854) |
8.7 | 26.0 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
8.6 | 43.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
8.6 | 43.1 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
8.6 | 8.6 | GO:0001975 | response to amphetamine(GO:0001975) |
8.6 | 60.2 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
8.6 | 8.6 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
8.6 | 60.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
8.6 | 34.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
8.6 | 42.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
8.6 | 34.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
8.5 | 25.6 | GO:0015817 | histidine transport(GO:0015817) |
8.5 | 17.0 | GO:0001757 | somite specification(GO:0001757) |
8.5 | 25.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
8.5 | 118.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
8.4 | 33.8 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
8.4 | 42.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
8.4 | 25.3 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
8.4 | 16.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
8.3 | 140.9 | GO:0007616 | long-term memory(GO:0007616) |
8.3 | 33.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
8.3 | 74.3 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
8.3 | 8.3 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
8.2 | 8.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
8.2 | 8.2 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
8.2 | 16.3 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
8.1 | 32.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
8.1 | 48.7 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
8.1 | 48.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
8.1 | 16.1 | GO:0060384 | innervation(GO:0060384) |
8.0 | 16.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
8.0 | 32.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
8.0 | 23.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
8.0 | 79.8 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
8.0 | 8.0 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
8.0 | 23.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
7.9 | 55.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
7.9 | 220.2 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
7.8 | 23.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
7.8 | 7.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
7.7 | 7.7 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
7.7 | 108.0 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
7.7 | 7.7 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
7.7 | 23.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
7.7 | 30.8 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
7.7 | 30.7 | GO:0043584 | nose development(GO:0043584) |
7.7 | 15.4 | GO:2000425 | regulation of apoptotic cell clearance(GO:2000425) |
7.7 | 7.7 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
7.7 | 7.7 | GO:0002339 | B cell selection(GO:0002339) |
7.7 | 184.0 | GO:0010107 | potassium ion import(GO:0010107) |
7.6 | 53.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
7.6 | 15.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
7.6 | 22.8 | GO:0043587 | tongue morphogenesis(GO:0043587) |
7.6 | 15.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
7.6 | 7.6 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
7.6 | 7.6 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
7.5 | 22.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
7.5 | 22.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
7.5 | 22.5 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
7.5 | 22.5 | GO:0060023 | soft palate development(GO:0060023) |
7.5 | 15.0 | GO:0014029 | neural crest formation(GO:0014029) |
7.5 | 22.5 | GO:0097503 | sialylation(GO:0097503) |
7.4 | 7.4 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
7.4 | 7.4 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
7.4 | 7.4 | GO:0031033 | myosin filament organization(GO:0031033) |
7.4 | 7.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
7.4 | 44.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
7.3 | 22.0 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
7.3 | 66.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
7.3 | 21.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
7.3 | 21.9 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
7.3 | 14.5 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
7.2 | 21.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
7.2 | 7.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
7.2 | 14.4 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
7.2 | 21.5 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
7.2 | 35.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
7.1 | 42.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
7.1 | 78.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
7.1 | 7.1 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
7.1 | 42.5 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
7.1 | 28.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
7.1 | 21.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
7.1 | 21.2 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
7.0 | 98.3 | GO:0021766 | hippocampus development(GO:0021766) |
7.0 | 21.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
7.0 | 48.9 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
7.0 | 14.0 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
7.0 | 20.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
7.0 | 7.0 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
6.9 | 13.9 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
6.9 | 374.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
6.9 | 27.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
6.9 | 20.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
6.9 | 6.9 | GO:0048382 | mesendoderm development(GO:0048382) |
6.9 | 34.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
6.8 | 20.5 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
6.8 | 6.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
6.8 | 20.4 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
6.8 | 87.8 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
6.7 | 20.2 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
6.7 | 6.7 | GO:0001993 | regulation of systemic arterial blood pressure by norepinephrine-epinephrine(GO:0001993) vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
6.7 | 13.4 | GO:0035106 | operant conditioning(GO:0035106) |
6.7 | 13.4 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
6.7 | 26.7 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
6.7 | 13.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
6.7 | 6.7 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
6.7 | 39.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
6.6 | 13.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
6.6 | 39.9 | GO:0015846 | polyamine transport(GO:0015846) |
6.6 | 6.6 | GO:0072053 | renal inner medulla development(GO:0072053) |
6.6 | 19.9 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
6.6 | 39.7 | GO:0032099 | negative regulation of appetite(GO:0032099) |
6.6 | 39.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
6.5 | 6.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
6.5 | 78.4 | GO:0021954 | central nervous system neuron development(GO:0021954) |
6.5 | 299.9 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
6.5 | 19.5 | GO:0060065 | uterus development(GO:0060065) |
6.5 | 12.9 | GO:0008355 | olfactory learning(GO:0008355) |
6.5 | 6.5 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
6.5 | 12.9 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
6.4 | 25.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
6.4 | 51.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
6.4 | 12.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
6.4 | 6.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
6.4 | 51.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
6.4 | 12.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
6.4 | 6.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
6.4 | 6.4 | GO:0060591 | chondroblast differentiation(GO:0060591) |
6.4 | 19.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
6.3 | 75.2 | GO:1905144 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
6.3 | 12.5 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
6.2 | 187.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
6.2 | 6.2 | GO:0072017 | distal tubule development(GO:0072017) |
6.2 | 12.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
6.2 | 12.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
6.2 | 18.7 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
6.2 | 12.4 | GO:0007520 | myoblast fusion(GO:0007520) |
6.2 | 80.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
6.2 | 12.3 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
6.2 | 24.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
6.1 | 6.1 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
6.1 | 12.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
6.1 | 12.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
6.1 | 24.5 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
6.1 | 18.3 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
6.1 | 6.1 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
6.1 | 36.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
6.1 | 6.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
6.1 | 6.1 | GO:0048645 | organ formation(GO:0048645) |
6.0 | 24.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
6.0 | 12.0 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
6.0 | 6.0 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
5.9 | 23.7 | GO:0060179 | male mating behavior(GO:0060179) |
5.9 | 23.7 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
5.9 | 17.8 | GO:0071599 | otic vesicle development(GO:0071599) |
5.9 | 23.6 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
5.9 | 23.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
5.9 | 17.7 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
5.9 | 17.6 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
5.9 | 17.6 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
5.9 | 58.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
5.9 | 117.2 | GO:0008306 | associative learning(GO:0008306) |
5.9 | 17.6 | GO:0021511 | spinal cord patterning(GO:0021511) |
5.8 | 11.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
5.8 | 5.8 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
5.8 | 17.5 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
5.8 | 5.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
5.8 | 17.4 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
5.8 | 5.8 | GO:0030901 | midbrain development(GO:0030901) |
5.8 | 23.0 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
5.8 | 5.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
5.8 | 11.5 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
5.7 | 5.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
5.7 | 11.5 | GO:0014014 | negative regulation of gliogenesis(GO:0014014) |
5.7 | 5.7 | GO:0021984 | adenohypophysis development(GO:0021984) |
5.7 | 62.8 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
5.7 | 17.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
5.7 | 56.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
5.7 | 45.3 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
5.7 | 5.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
5.6 | 5.6 | GO:1904023 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
5.6 | 282.3 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
5.6 | 22.6 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
5.6 | 73.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
5.6 | 16.9 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
5.6 | 16.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
5.6 | 11.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
5.6 | 22.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
5.6 | 5.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
5.6 | 5.6 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
5.6 | 16.8 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
5.6 | 11.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
5.5 | 16.6 | GO:0007405 | neuroblast proliferation(GO:0007405) |
5.5 | 11.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
5.5 | 22.1 | GO:0016322 | neuron remodeling(GO:0016322) |
5.5 | 16.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
5.5 | 22.1 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
5.5 | 16.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
5.5 | 16.5 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
5.5 | 11.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
5.5 | 5.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) |
5.5 | 27.4 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
5.5 | 32.9 | GO:1900120 | regulation of receptor binding(GO:1900120) |
5.5 | 11.0 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
5.5 | 5.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
5.5 | 49.3 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
5.5 | 16.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
5.4 | 5.4 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
5.4 | 16.3 | GO:0050955 | thermoception(GO:0050955) |
5.4 | 201.1 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
5.4 | 10.9 | GO:0061055 | myotome development(GO:0061055) |
5.4 | 10.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
5.4 | 27.1 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
5.4 | 16.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
5.4 | 59.4 | GO:0036065 | fucosylation(GO:0036065) |
5.4 | 32.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
5.4 | 16.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
5.4 | 32.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
5.4 | 16.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
5.4 | 16.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
5.4 | 21.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
5.3 | 16.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
5.3 | 64.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
5.3 | 5.3 | GO:0060618 | nipple development(GO:0060618) |
5.3 | 10.6 | GO:0021554 | optic nerve development(GO:0021554) |
5.3 | 21.3 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) |
5.3 | 15.9 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
5.3 | 15.9 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
5.3 | 15.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
5.3 | 42.3 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
5.3 | 10.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
5.3 | 5.3 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
5.2 | 36.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
5.2 | 10.5 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
5.2 | 20.9 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
5.2 | 5.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
5.2 | 10.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
5.2 | 31.3 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
5.2 | 10.4 | GO:0002159 | desmosome assembly(GO:0002159) |
5.2 | 10.4 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
5.2 | 25.9 | GO:0003407 | neural retina development(GO:0003407) |
5.2 | 20.7 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
5.2 | 5.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
5.2 | 36.1 | GO:0006012 | galactose metabolic process(GO:0006012) |
5.1 | 5.1 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
5.1 | 5.1 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
5.1 | 51.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
5.1 | 10.2 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
5.1 | 15.4 | GO:0016264 | gap junction assembly(GO:0016264) |
5.1 | 5.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
5.1 | 15.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
5.1 | 5.1 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
5.1 | 10.2 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
5.1 | 5.1 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
5.0 | 65.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
5.0 | 10.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
5.0 | 40.1 | GO:0015813 | L-glutamate transport(GO:0015813) |
5.0 | 10.0 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
5.0 | 10.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
5.0 | 50.0 | GO:0003334 | keratinocyte development(GO:0003334) |
5.0 | 19.9 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
5.0 | 10.0 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
5.0 | 19.9 | GO:0042756 | drinking behavior(GO:0042756) |
5.0 | 14.9 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
5.0 | 14.9 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
4.9 | 14.8 | GO:0030578 | PML body organization(GO:0030578) |
4.9 | 9.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
4.9 | 14.8 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
4.9 | 4.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
4.9 | 14.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
4.9 | 14.7 | GO:0032305 | positive regulation of icosanoid secretion(GO:0032305) |
4.9 | 274.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
4.9 | 19.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
4.9 | 9.7 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
4.9 | 43.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
4.8 | 19.4 | GO:1990403 | embryonic brain development(GO:1990403) |
4.8 | 48.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
4.8 | 9.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
4.8 | 4.8 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
4.8 | 47.9 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
4.8 | 43.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
4.8 | 52.6 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
4.8 | 14.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
4.8 | 14.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
4.8 | 19.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
4.8 | 9.5 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
4.7 | 28.5 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
4.7 | 23.7 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
4.7 | 14.2 | GO:0015889 | cobalamin transport(GO:0015889) |
4.7 | 14.1 | GO:0035107 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
4.7 | 37.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
4.7 | 9.4 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
4.7 | 4.7 | GO:0003134 | BMP signaling pathway involved in heart induction(GO:0003130) endodermal-mesodermal cell signaling(GO:0003133) endodermal-mesodermal cell signaling involved in heart induction(GO:0003134) |
4.7 | 9.3 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
4.7 | 9.3 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
4.7 | 14.0 | GO:0042637 | catagen(GO:0042637) |
4.7 | 46.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
4.6 | 18.6 | GO:0001893 | maternal placenta development(GO:0001893) |
4.6 | 37.2 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
4.6 | 97.4 | GO:0060612 | adipose tissue development(GO:0060612) |
4.6 | 4.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
4.6 | 4.6 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
4.6 | 18.4 | GO:0048678 | response to axon injury(GO:0048678) |
4.6 | 9.2 | GO:0008078 | mesodermal cell migration(GO:0008078) |
4.6 | 23.0 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
4.6 | 13.8 | GO:0003383 | apical constriction(GO:0003383) |
4.6 | 22.9 | GO:0090596 | sensory organ morphogenesis(GO:0090596) |
4.6 | 18.3 | GO:1902855 | regulation of nonmotile primary cilium assembly(GO:1902855) |
4.6 | 9.1 | GO:0050655 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
4.6 | 36.5 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
4.6 | 4.6 | GO:0040009 | regulation of growth rate(GO:0040009) |
4.6 | 9.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
4.5 | 18.2 | GO:0033762 | response to glucagon(GO:0033762) |
4.5 | 9.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
4.5 | 27.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
4.5 | 9.0 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
4.5 | 4.5 | GO:0060157 | urinary bladder development(GO:0060157) |
4.5 | 13.5 | GO:0015819 | lysine transport(GO:0015819) |
4.5 | 18.0 | GO:0002063 | chondrocyte development(GO:0002063) |
4.5 | 22.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
4.5 | 31.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
4.4 | 4.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
4.4 | 4.4 | GO:0033122 | negative regulation of purine nucleotide catabolic process(GO:0033122) |
4.4 | 13.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
4.4 | 26.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
4.4 | 13.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
4.4 | 17.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
4.4 | 4.4 | GO:0051181 | cofactor transport(GO:0051181) |
4.4 | 8.8 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
4.4 | 13.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
4.4 | 13.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
4.4 | 48.0 | GO:0008088 | axo-dendritic transport(GO:0008088) |
4.4 | 30.5 | GO:0048339 | paraxial mesoderm development(GO:0048339) |
4.3 | 73.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
4.3 | 4.3 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
4.3 | 8.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
4.3 | 21.6 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
4.3 | 30.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
4.3 | 12.9 | GO:0014003 | oligodendrocyte development(GO:0014003) |
4.3 | 12.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
4.3 | 86.1 | GO:0035113 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
4.3 | 17.2 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
4.3 | 12.9 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
4.3 | 30.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
4.3 | 8.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
4.3 | 38.3 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
4.3 | 12.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
4.2 | 8.5 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
4.2 | 16.9 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
4.2 | 29.6 | GO:0021988 | olfactory lobe development(GO:0021988) |
4.2 | 25.4 | GO:0072364 | regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
4.2 | 29.4 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
4.2 | 4.2 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
4.2 | 25.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
4.1 | 58.0 | GO:1900006 | positive regulation of dendrite development(GO:1900006) |
4.1 | 12.4 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
4.1 | 8.3 | GO:0051593 | response to folic acid(GO:0051593) |
4.1 | 4.1 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
4.1 | 12.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
4.1 | 20.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
4.1 | 37.0 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
4.1 | 12.3 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
4.1 | 8.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
4.1 | 12.3 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
4.1 | 24.5 | GO:0008347 | glial cell migration(GO:0008347) |
4.1 | 4.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
4.1 | 12.2 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
4.1 | 8.1 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
4.1 | 12.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
4.0 | 20.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
4.0 | 4.0 | GO:0015705 | iodide transport(GO:0015705) |
4.0 | 16.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
4.0 | 8.0 | GO:0036315 | cellular response to sterol(GO:0036315) |
4.0 | 16.0 | GO:2000738 | positive regulation of stem cell differentiation(GO:2000738) |
4.0 | 8.0 | GO:0030049 | muscle filament sliding(GO:0030049) |
4.0 | 15.9 | GO:0070417 | cellular response to cold(GO:0070417) |
4.0 | 11.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
4.0 | 23.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
4.0 | 11.9 | GO:0001927 | exocyst assembly(GO:0001927) |
4.0 | 95.0 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
4.0 | 130.6 | GO:0001578 | microtubule bundle formation(GO:0001578) |
4.0 | 7.9 | GO:0051013 | microtubule severing(GO:0051013) |
4.0 | 126.5 | GO:0050808 | synapse organization(GO:0050808) |
3.9 | 15.8 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
3.9 | 11.8 | GO:0015747 | urate transport(GO:0015747) |
3.9 | 43.3 | GO:0016358 | dendrite development(GO:0016358) |
3.9 | 7.9 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
3.9 | 7.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
3.9 | 7.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
3.9 | 3.9 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
3.9 | 3.9 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
3.9 | 34.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
3.9 | 38.8 | GO:0031507 | heterochromatin assembly(GO:0031507) |
3.9 | 15.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
3.9 | 7.7 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
3.8 | 11.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
3.8 | 11.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
3.8 | 11.5 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
3.8 | 7.7 | GO:0033504 | floor plate development(GO:0033504) |
3.8 | 3.8 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
3.8 | 26.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
3.8 | 11.4 | GO:0007567 | parturition(GO:0007567) |
3.8 | 11.4 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
3.8 | 3.8 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
3.8 | 3.8 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
3.8 | 53.1 | GO:0032400 | melanosome localization(GO:0032400) |
3.8 | 30.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
3.8 | 3.8 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
3.8 | 11.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
3.8 | 15.1 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
3.8 | 18.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
3.8 | 11.3 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
3.8 | 3.8 | GO:0033238 | regulation of cellular amine metabolic process(GO:0033238) |
3.8 | 3.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
3.7 | 7.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
3.7 | 3.7 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
3.7 | 7.3 | GO:0060004 | reflex(GO:0060004) |
3.7 | 197.4 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
3.7 | 7.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
3.7 | 11.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
3.6 | 7.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
3.6 | 21.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
3.6 | 14.5 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
3.6 | 7.2 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) positive regulation of activation of Janus kinase activity(GO:0010536) |
3.6 | 3.6 | GO:0032026 | response to magnesium ion(GO:0032026) |
3.6 | 25.3 | GO:0006108 | malate metabolic process(GO:0006108) |
3.6 | 10.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
3.6 | 10.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
3.6 | 21.6 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
3.6 | 10.8 | GO:0015872 | dopamine transport(GO:0015872) |
3.6 | 247.9 | GO:0007409 | axonogenesis(GO:0007409) |
3.6 | 21.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
3.6 | 21.5 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
3.6 | 28.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
3.6 | 7.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
3.6 | 7.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
3.6 | 14.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
3.6 | 7.1 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
3.5 | 3.5 | GO:0070307 | lens fiber cell development(GO:0070307) |
3.5 | 3.5 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
3.5 | 7.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
3.5 | 7.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
3.5 | 14.1 | GO:0030091 | protein repair(GO:0030091) |
3.5 | 10.6 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
3.5 | 52.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
3.5 | 3.5 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
3.5 | 42.3 | GO:0021543 | pallium development(GO:0021543) |
3.5 | 7.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
3.5 | 3.5 | GO:0098739 | import across plasma membrane(GO:0098739) |
3.5 | 13.9 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
3.5 | 3.5 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
3.5 | 10.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
3.5 | 6.9 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
3.4 | 6.9 | GO:0071711 | basement membrane organization(GO:0071711) |
3.4 | 48.1 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
3.4 | 3.4 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
3.4 | 10.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
3.4 | 6.8 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
3.4 | 23.8 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
3.4 | 13.6 | GO:1904888 | cranial skeletal system development(GO:1904888) |
3.4 | 23.7 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
3.4 | 6.7 | GO:0030823 | regulation of cGMP metabolic process(GO:0030823) |
3.4 | 6.7 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
3.3 | 3.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
3.3 | 10.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
3.3 | 3.3 | GO:0021871 | forebrain regionalization(GO:0021871) |
3.3 | 6.7 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
3.3 | 10.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
3.3 | 6.7 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
3.3 | 26.7 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
3.3 | 16.6 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
3.3 | 6.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
3.3 | 3.3 | GO:0045974 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
3.3 | 6.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
3.3 | 9.9 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
3.3 | 19.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
3.3 | 13.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
3.3 | 45.8 | GO:0030900 | forebrain development(GO:0030900) |
3.3 | 16.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
3.3 | 6.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
3.2 | 9.7 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
3.2 | 6.5 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
3.2 | 3.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
3.2 | 9.7 | GO:0046909 | intermembrane transport(GO:0046909) |
3.2 | 3.2 | GO:0090383 | phagosome acidification(GO:0090383) |
3.2 | 9.6 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
3.2 | 9.6 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
3.2 | 28.7 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
3.2 | 3.2 | GO:0042891 | antibiotic transport(GO:0042891) |
3.1 | 6.3 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
3.1 | 6.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
3.1 | 3.1 | GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
3.1 | 6.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
3.1 | 9.3 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
3.1 | 6.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
3.1 | 3.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
3.1 | 9.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
3.1 | 3.1 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
3.1 | 6.1 | GO:0010288 | response to lead ion(GO:0010288) |
3.0 | 9.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
3.0 | 6.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
3.0 | 12.1 | GO:0090042 | tubulin deacetylation(GO:0090042) |
3.0 | 3.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
3.0 | 9.0 | GO:1903232 | melanosome assembly(GO:1903232) |
3.0 | 3.0 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
3.0 | 3.0 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
3.0 | 9.0 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
3.0 | 35.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
3.0 | 8.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
2.9 | 20.6 | GO:0002176 | male germ cell proliferation(GO:0002176) |
2.9 | 23.5 | GO:0046677 | response to antibiotic(GO:0046677) |
2.9 | 23.4 | GO:0048747 | muscle fiber development(GO:0048747) |
2.9 | 8.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
2.9 | 8.8 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
2.9 | 40.8 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
2.9 | 5.8 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
2.9 | 2.9 | GO:0009414 | response to water deprivation(GO:0009414) cellular response to water stimulus(GO:0071462) |
2.9 | 8.7 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
2.9 | 2.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
2.9 | 26.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
2.9 | 8.7 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
2.9 | 5.8 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
2.9 | 23.0 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
2.9 | 20.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
2.9 | 14.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
2.9 | 2.9 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
2.8 | 2.8 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
2.8 | 2.8 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
2.8 | 17.0 | GO:0051450 | myoblast proliferation(GO:0051450) |
2.8 | 8.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
2.8 | 19.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
2.8 | 22.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
2.8 | 17.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
2.8 | 8.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
2.8 | 5.6 | GO:0006477 | protein sulfation(GO:0006477) |
2.8 | 16.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
2.8 | 19.5 | GO:1903202 | negative regulation of oxidative stress-induced cell death(GO:1903202) |
2.8 | 5.6 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
2.8 | 44.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
2.8 | 33.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
2.8 | 11.1 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
2.8 | 5.5 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
2.8 | 8.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
2.8 | 8.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
2.8 | 24.8 | GO:0034389 | lipid particle organization(GO:0034389) |
2.7 | 32.7 | GO:0007588 | excretion(GO:0007588) |
2.7 | 57.3 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
2.7 | 2.7 | GO:1905214 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) regulation of RNA binding(GO:1905214) positive regulation of RNA binding(GO:1905216) |
2.7 | 8.1 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
2.7 | 2.7 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
2.7 | 2.7 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
2.7 | 70.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
2.7 | 148.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
2.7 | 13.5 | GO:0014002 | astrocyte development(GO:0014002) |
2.7 | 8.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
2.7 | 13.4 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
2.7 | 8.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
2.7 | 2.7 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.7 | 5.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
2.7 | 26.6 | GO:1902176 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
2.7 | 53.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
2.7 | 2.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
2.6 | 2.6 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
2.6 | 7.9 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
2.6 | 2.6 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
2.6 | 7.9 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
2.6 | 7.8 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
2.6 | 15.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
2.6 | 2.6 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
2.6 | 5.2 | GO:0034351 | negative regulation of glial cell apoptotic process(GO:0034351) |
2.6 | 5.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.6 | 2.6 | GO:0046098 | guanine metabolic process(GO:0046098) |
2.6 | 2.6 | GO:0007632 | visual behavior(GO:0007632) |
2.6 | 2.6 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
2.6 | 2.6 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
2.6 | 7.7 | GO:0048539 | bone marrow development(GO:0048539) |
2.6 | 7.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
2.6 | 2.6 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
2.5 | 7.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
2.5 | 2.5 | GO:0048588 | developmental cell growth(GO:0048588) |
2.5 | 7.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
2.5 | 2.5 | GO:0051642 | centrosome localization(GO:0051642) |
2.5 | 12.6 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
2.5 | 12.6 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
2.5 | 5.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
2.5 | 2.5 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
2.5 | 17.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
2.5 | 2.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
2.5 | 5.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
2.5 | 10.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
2.5 | 2.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
2.5 | 5.0 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
2.5 | 27.3 | GO:0035329 | hippo signaling(GO:0035329) |
2.5 | 42.1 | GO:0055001 | muscle cell development(GO:0055001) |
2.5 | 7.4 | GO:0035994 | response to muscle stretch(GO:0035994) |
2.5 | 2.5 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
2.5 | 2.5 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
2.5 | 73.5 | GO:0001764 | neuron migration(GO:0001764) |
2.4 | 7.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
2.4 | 7.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
2.4 | 7.3 | GO:0018158 | protein oxidation(GO:0018158) |
2.4 | 2.4 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
2.4 | 19.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
2.4 | 2.4 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) |
2.4 | 45.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
2.4 | 2.4 | GO:0034650 | cortisol metabolic process(GO:0034650) |
2.4 | 2.4 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
2.4 | 2.4 | GO:0015755 | fructose transport(GO:0015755) |
2.3 | 11.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
2.3 | 11.7 | GO:0055021 | regulation of cardiac muscle tissue growth(GO:0055021) |
2.3 | 7.0 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
2.3 | 7.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.3 | 7.0 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
2.3 | 2.3 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
2.3 | 7.0 | GO:0032202 | telomere assembly(GO:0032202) |
2.3 | 4.7 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
2.3 | 32.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
2.3 | 7.0 | GO:0007097 | nuclear migration(GO:0007097) |
2.3 | 11.6 | GO:0050804 | modulation of synaptic transmission(GO:0050804) |
2.3 | 23.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
2.3 | 6.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
2.3 | 4.6 | GO:0043366 | beta selection(GO:0043366) |
2.3 | 2.3 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
2.3 | 9.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
2.3 | 4.5 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
2.3 | 6.8 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
2.3 | 4.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
2.3 | 2.3 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
2.3 | 40.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
2.3 | 11.3 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
2.3 | 13.5 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
2.2 | 4.5 | GO:0033227 | dsRNA transport(GO:0033227) |
2.2 | 4.5 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
2.2 | 2.2 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
2.2 | 4.5 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.2 | 2.2 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) |
2.2 | 2.2 | GO:0051036 | regulation of multivesicular body size(GO:0010796) regulation of endosome size(GO:0051036) |
2.2 | 13.2 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
2.2 | 4.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.2 | 15.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
2.2 | 8.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
2.2 | 21.9 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
2.2 | 4.4 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
2.2 | 13.0 | GO:0015074 | DNA integration(GO:0015074) |
2.2 | 75.7 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
2.2 | 13.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
2.1 | 6.4 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
2.1 | 4.3 | GO:0045933 | positive regulation of muscle contraction(GO:0045933) |
2.1 | 4.3 | GO:0002934 | desmosome organization(GO:0002934) |
2.1 | 4.3 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
2.1 | 25.6 | GO:0042471 | ear morphogenesis(GO:0042471) |
2.1 | 6.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
2.1 | 16.8 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
2.1 | 8.4 | GO:0051451 | myoblast migration(GO:0051451) |
2.1 | 4.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
2.1 | 2.1 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
2.1 | 4.2 | GO:0048254 | snoRNA localization(GO:0048254) |
2.1 | 4.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
2.1 | 10.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
2.1 | 6.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
2.0 | 20.5 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
2.0 | 2.0 | GO:0007525 | somatic muscle development(GO:0007525) |
2.0 | 4.1 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
2.0 | 6.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
2.0 | 6.1 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
2.0 | 4.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
2.0 | 6.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
2.0 | 8.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
2.0 | 6.0 | GO:0051775 | response to redox state(GO:0051775) |
2.0 | 22.1 | GO:0003341 | cilium movement(GO:0003341) |
2.0 | 18.0 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
2.0 | 2.0 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
2.0 | 2.0 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
2.0 | 17.9 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
2.0 | 23.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
2.0 | 4.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
2.0 | 4.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
2.0 | 5.9 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
2.0 | 3.9 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
2.0 | 3.9 | GO:0001696 | gastric acid secretion(GO:0001696) |
2.0 | 13.7 | GO:0010883 | regulation of lipid storage(GO:0010883) |
1.9 | 25.2 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
1.9 | 3.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
1.9 | 19.3 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
1.9 | 13.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
1.9 | 5.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
1.9 | 3.8 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.9 | 9.5 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.9 | 5.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.9 | 9.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
1.9 | 3.8 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
1.9 | 3.8 | GO:0048069 | eye pigmentation(GO:0048069) |
1.9 | 132.2 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
1.9 | 5.7 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
1.9 | 60.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
1.9 | 15.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.9 | 9.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.9 | 7.5 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
1.9 | 22.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
1.9 | 5.6 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
1.9 | 18.6 | GO:0048286 | lung alveolus development(GO:0048286) |
1.9 | 1.9 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
1.9 | 11.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
1.9 | 5.6 | GO:0007000 | nucleolus organization(GO:0007000) |
1.8 | 11.0 | GO:0045056 | transcytosis(GO:0045056) |
1.8 | 9.2 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.8 | 9.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
1.8 | 5.4 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
1.8 | 3.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
1.8 | 1.8 | GO:0048736 | appendage development(GO:0048736) limb development(GO:0060173) |
1.8 | 16.1 | GO:0043248 | proteasome assembly(GO:0043248) |
1.8 | 9.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.8 | 3.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
1.8 | 7.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.8 | 3.6 | GO:0015867 | ATP transport(GO:0015867) |
1.8 | 7.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
1.8 | 24.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.7 | 1.7 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.7 | 26.2 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
1.7 | 1.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.7 | 10.4 | GO:0015844 | monoamine transport(GO:0015844) |
1.7 | 1.7 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
1.7 | 10.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.7 | 8.6 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.7 | 3.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.7 | 6.9 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.7 | 30.8 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
1.7 | 3.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.7 | 1.7 | GO:0060419 | heart growth(GO:0060419) |
1.7 | 32.3 | GO:0034605 | cellular response to heat(GO:0034605) |
1.7 | 3.4 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
1.7 | 13.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
1.7 | 11.9 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.7 | 6.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
1.7 | 54.2 | GO:0010975 | regulation of neuron projection development(GO:0010975) |
1.7 | 5.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.7 | 6.7 | GO:0035878 | nail development(GO:0035878) |
1.7 | 31.8 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
1.7 | 3.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
1.7 | 13.4 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
1.7 | 28.4 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
1.7 | 5.0 | GO:0052422 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.7 | 15.0 | GO:0061436 | establishment of skin barrier(GO:0061436) |
1.7 | 8.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
1.7 | 1.7 | GO:0071725 | response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
1.7 | 8.3 | GO:0002335 | mature B cell differentiation(GO:0002335) |
1.6 | 9.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
1.6 | 14.8 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
1.6 | 1.6 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
1.6 | 4.9 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
1.6 | 3.3 | GO:0060914 | heart formation(GO:0060914) |
1.6 | 6.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
1.6 | 1.6 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
1.6 | 4.9 | GO:0032288 | myelin assembly(GO:0032288) |
1.6 | 6.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.6 | 8.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
1.6 | 1.6 | GO:0051953 | negative regulation of amine transport(GO:0051953) |
1.6 | 1.6 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
1.6 | 11.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
1.6 | 22.3 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
1.6 | 3.2 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
1.6 | 1.6 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
1.6 | 1.6 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
1.6 | 6.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.6 | 9.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.6 | 10.9 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
1.6 | 35.9 | GO:0045727 | positive regulation of translation(GO:0045727) |
1.6 | 7.8 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
1.5 | 7.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.5 | 10.8 | GO:0007041 | lysosomal transport(GO:0007041) |
1.5 | 13.9 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
1.5 | 4.6 | GO:0015884 | folic acid transport(GO:0015884) |
1.5 | 19.9 | GO:0051262 | protein tetramerization(GO:0051262) |
1.5 | 32.1 | GO:0018345 | protein palmitoylation(GO:0018345) |
1.5 | 3.0 | GO:0097186 | amelogenesis(GO:0097186) |
1.5 | 10.6 | GO:0010524 | positive regulation of calcium ion transport into cytosol(GO:0010524) |
1.5 | 1.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
1.5 | 4.5 | GO:0019695 | choline metabolic process(GO:0019695) |
1.5 | 3.0 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.5 | 1.5 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
1.5 | 25.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
1.5 | 3.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.5 | 10.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.5 | 4.5 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
1.5 | 370.9 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
1.5 | 1.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
1.5 | 4.4 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) |
1.5 | 4.4 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.5 | 4.4 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.5 | 7.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
1.5 | 4.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.5 | 7.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
1.5 | 2.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
1.5 | 10.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
1.4 | 2.9 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
1.4 | 4.3 | GO:0007512 | adult heart development(GO:0007512) |
1.4 | 4.3 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
1.4 | 2.9 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.4 | 2.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.4 | 1.4 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
1.4 | 28.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
1.4 | 1.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
1.4 | 2.8 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
1.4 | 2.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.4 | 2.8 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
1.4 | 12.5 | GO:0048240 | sperm capacitation(GO:0048240) |
1.4 | 5.6 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
1.4 | 15.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.4 | 2.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.4 | 17.6 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
1.3 | 1.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.3 | 6.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.3 | 1.3 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.3 | 5.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
1.3 | 2.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.3 | 4.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.3 | 5.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
1.3 | 1.3 | GO:0031102 | neuron projection regeneration(GO:0031102) |
1.3 | 2.6 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
1.3 | 1.3 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.3 | 5.2 | GO:0006415 | translational termination(GO:0006415) |
1.3 | 3.9 | GO:0051182 | coenzyme transport(GO:0051182) |
1.3 | 1.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.3 | 5.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.3 | 15.7 | GO:0048812 | neuron projection morphogenesis(GO:0048812) |
1.3 | 6.5 | GO:0042246 | tissue regeneration(GO:0042246) |
1.3 | 5.2 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
1.3 | 1.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
1.3 | 3.9 | GO:0009106 | lipoate metabolic process(GO:0009106) |
1.3 | 2.5 | GO:0045713 | low-density lipoprotein particle receptor biosynthetic process(GO:0045713) |
1.3 | 1.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.3 | 10.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
1.3 | 1.3 | GO:2000018 | regulation of male gonad development(GO:2000018) positive regulation of male gonad development(GO:2000020) |
1.3 | 11.3 | GO:0014850 | response to muscle activity(GO:0014850) |
1.3 | 2.5 | GO:0032439 | endosome localization(GO:0032439) |
1.3 | 8.8 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.3 | 11.3 | GO:0007613 | memory(GO:0007613) |
1.2 | 3.7 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.2 | 1.2 | GO:0097421 | liver regeneration(GO:0097421) |
1.2 | 3.7 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.2 | 3.7 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
1.2 | 2.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.2 | 1.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
1.2 | 11.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.2 | 7.3 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
1.2 | 9.8 | GO:0006029 | proteoglycan metabolic process(GO:0006029) |
1.2 | 1.2 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
1.2 | 1.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
1.2 | 22.9 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
1.2 | 4.8 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
1.2 | 27.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.2 | 17.9 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
1.2 | 2.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.2 | 11.9 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
1.2 | 7.1 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
1.2 | 1.2 | GO:0033233 | regulation of protein sumoylation(GO:0033233) negative regulation of protein sumoylation(GO:0033234) |
1.2 | 2.3 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
1.2 | 3.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.2 | 4.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
1.2 | 5.8 | GO:0006528 | asparagine metabolic process(GO:0006528) |
1.2 | 1.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.2 | 11.6 | GO:0001881 | receptor recycling(GO:0001881) |
1.2 | 1.2 | GO:0090148 | membrane fission(GO:0090148) |
1.2 | 2.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
1.1 | 3.4 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.1 | 4.6 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
1.1 | 1.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
1.1 | 13.6 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
1.1 | 5.6 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
1.1 | 7.9 | GO:1904871 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
1.1 | 1.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.1 | 9.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
1.1 | 11.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.1 | 1.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
1.1 | 22.1 | GO:0001654 | eye development(GO:0001654) |
1.1 | 2.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
1.1 | 2.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.1 | 1.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.1 | 3.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.1 | 2.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.1 | 4.4 | GO:0043206 | extracellular fibril organization(GO:0043206) |
1.1 | 1.1 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
1.1 | 10.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
1.1 | 10.7 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
1.1 | 1.1 | GO:0070268 | cornification(GO:0070268) |
1.0 | 7.3 | GO:0009268 | response to pH(GO:0009268) |
1.0 | 18.9 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
1.0 | 14.6 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
1.0 | 3.1 | GO:0030010 | establishment of cell polarity(GO:0030010) |
1.0 | 7.2 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.0 | 1.0 | GO:0042762 | regulation of sulfur metabolic process(GO:0042762) |
1.0 | 1.0 | GO:0034763 | negative regulation of transmembrane transport(GO:0034763) |
1.0 | 2.0 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.0 | 4.1 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
1.0 | 1.0 | GO:0046655 | folic acid metabolic process(GO:0046655) |
1.0 | 23.3 | GO:0070206 | protein trimerization(GO:0070206) |
1.0 | 5.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
1.0 | 23.1 | GO:0015914 | phospholipid transport(GO:0015914) |
1.0 | 3.0 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.0 | 5.0 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
1.0 | 4.0 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
1.0 | 7.0 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
1.0 | 5.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.0 | 6.0 | GO:0034394 | protein localization to cell surface(GO:0034394) |
1.0 | 2.0 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
1.0 | 16.8 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
1.0 | 4.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
1.0 | 2.9 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
1.0 | 2.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
1.0 | 3.9 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.0 | 4.9 | GO:0007141 | male meiosis I(GO:0007141) |
1.0 | 20.4 | GO:0030336 | negative regulation of cell migration(GO:0030336) |
1.0 | 1.9 | GO:0048515 | spermatid differentiation(GO:0048515) |
1.0 | 5.7 | GO:0007140 | male meiosis(GO:0007140) |
0.9 | 14.2 | GO:0006101 | citrate metabolic process(GO:0006101) |
0.9 | 1.9 | GO:0030576 | Cajal body organization(GO:0030576) |
0.9 | 3.8 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.9 | 1.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.9 | 2.8 | GO:0090656 | t-circle formation(GO:0090656) |
0.9 | 2.8 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.9 | 0.9 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.9 | 9.4 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.9 | 0.9 | GO:0032252 | secretory granule localization(GO:0032252) |
0.9 | 4.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.9 | 4.5 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.9 | 2.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.9 | 11.7 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.9 | 8.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.9 | 0.9 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.9 | 13.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.9 | 0.9 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.9 | 0.9 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.9 | 0.9 | GO:0018216 | peptidyl-arginine methylation(GO:0018216) histone arginine methylation(GO:0034969) histone H4-R3 methylation(GO:0043985) |
0.9 | 1.7 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.9 | 5.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.9 | 6.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.9 | 1.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.9 | 0.9 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.9 | 2.6 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.9 | 4.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.8 | 4.2 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.8 | 1.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.8 | 7.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.8 | 7.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.8 | 0.8 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.8 | 1.6 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
0.8 | 0.8 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.8 | 0.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.8 | 3.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.8 | 0.8 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.8 | 2.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.8 | 2.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.8 | 0.8 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.8 | 0.8 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.8 | 2.4 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.8 | 2.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.8 | 3.2 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.8 | 3.2 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.8 | 0.8 | GO:0097709 | wound healing involved in inflammatory response(GO:0002246) connective tissue replacement involved in inflammatory response wound healing(GO:0002248) inflammatory response to wounding(GO:0090594) connective tissue replacement(GO:0097709) |
0.8 | 0.8 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.8 | 7.1 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.8 | 2.3 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.8 | 1.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.8 | 1.5 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.8 | 3.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.8 | 0.8 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.8 | 22.8 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.8 | 4.5 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.8 | 2.3 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.7 | 2.2 | GO:0009249 | protein lipoylation(GO:0009249) |
0.7 | 3.7 | GO:0071569 | protein ufmylation(GO:0071569) |
0.7 | 5.9 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.7 | 9.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.7 | 1.5 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.7 | 2.9 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.7 | 3.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.7 | 4.4 | GO:0033622 | integrin activation(GO:0033622) |
0.7 | 1.4 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.7 | 3.6 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.7 | 2.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.7 | 1.4 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.7 | 2.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.7 | 2.8 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.7 | 1.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.7 | 2.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.7 | 1.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.7 | 1.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.7 | 1.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.7 | 2.0 | GO:0007602 | phototransduction(GO:0007602) |
0.7 | 4.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.7 | 10.1 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.7 | 2.7 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.7 | 2.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.7 | 26.0 | GO:0043062 | extracellular structure organization(GO:0043062) |
0.7 | 0.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.7 | 3.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.7 | 0.7 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.7 | 0.7 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.7 | 23.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.7 | 4.6 | GO:0042407 | cristae formation(GO:0042407) |
0.6 | 2.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.6 | 2.6 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.6 | 7.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.6 | 1.9 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.6 | 6.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.6 | 0.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.6 | 1.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 1.9 | GO:0030242 | pexophagy(GO:0030242) |
0.6 | 1.8 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.6 | 14.1 | GO:0008217 | regulation of blood pressure(GO:0008217) |
0.6 | 0.6 | GO:0014047 | glutamate secretion(GO:0014047) |
0.6 | 0.6 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.6 | 0.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.6 | 4.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.6 | 3.0 | GO:0002385 | mucosal immune response(GO:0002385) |
0.6 | 4.7 | GO:0030317 | sperm motility(GO:0030317) |
0.6 | 1.2 | GO:0046530 | photoreceptor cell differentiation(GO:0046530) |
0.6 | 0.6 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.6 | 1.8 | GO:0032506 | cytokinetic process(GO:0032506) |
0.6 | 1.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.6 | 2.9 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.6 | 1.7 | GO:0098856 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.6 | 2.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.6 | 0.6 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.6 | 0.6 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.6 | 0.6 | GO:0048521 | negative regulation of behavior(GO:0048521) |
0.6 | 5.6 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.6 | 0.6 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.6 | 0.6 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.6 | 2.2 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.5 | 5.5 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.5 | 6.0 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.5 | 10.4 | GO:0002548 | monocyte chemotaxis(GO:0002548) |
0.5 | 2.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.5 | 3.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.5 | 0.5 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.5 | 5.9 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.5 | 3.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.5 | 1.6 | GO:0042511 | positive regulation of tyrosine phosphorylation of Stat1 protein(GO:0042511) |
0.5 | 0.5 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.5 | 1.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.5 | 1.6 | GO:0045354 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.5 | 6.4 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.5 | 1.1 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.5 | 3.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.5 | 1.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 15.9 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.5 | 3.0 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.5 | 1.5 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.5 | 1.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.5 | 0.5 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 4.0 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.5 | 0.5 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.5 | 6.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.5 | 2.9 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.5 | 1.9 | GO:0035561 | regulation of chromatin binding(GO:0035561) |
0.5 | 0.5 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.5 | 0.5 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.5 | 2.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.5 | 1.4 | GO:0061512 | protein localization to cilium(GO:0061512) |
0.5 | 0.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.5 | 1.4 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.5 | 9.1 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.4 | 0.4 | GO:0001895 | retina homeostasis(GO:0001895) |
0.4 | 1.3 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.4 | 0.9 | GO:0080009 | mRNA methylation(GO:0080009) |
0.4 | 7.0 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
0.4 | 0.4 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 1.3 | GO:0055007 | cardiac muscle cell differentiation(GO:0055007) |
0.4 | 16.0 | GO:0035195 | gene silencing by miRNA(GO:0035195) |
0.4 | 4.6 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.4 | 1.7 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.4 | 3.3 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
0.4 | 0.8 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.4 | 13.9 | GO:0005977 | glycogen metabolic process(GO:0005977) cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.4 | 6.9 | GO:0006813 | potassium ion transport(GO:0006813) |
0.4 | 0.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.4 | 0.4 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.4 | 13.7 | GO:0071772 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.4 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 0.4 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.4 | 0.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.4 | 0.4 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.4 | 41.5 | GO:0007286 | spermatid development(GO:0007286) |
0.4 | 3.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.4 | 0.4 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 3.9 | GO:0010959 | regulation of metal ion transport(GO:0010959) |
0.4 | 1.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.4 | 1.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.4 | 1.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.4 | 2.5 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.4 | 0.4 | GO:0043305 | negative regulation of mast cell activation involved in immune response(GO:0033007) negative regulation of mast cell degranulation(GO:0043305) |
0.4 | 0.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 0.7 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.3 | 0.7 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 0.7 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 0.3 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.3 | 0.6 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 0.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.3 | 1.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.3 | 0.3 | GO:0046514 | glycosphingolipid catabolic process(GO:0046479) ceramide catabolic process(GO:0046514) |
0.3 | 0.9 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.3 | 0.6 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.3 | 0.9 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.3 | 0.3 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.3 | 1.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 1.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.3 | 1.5 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.3 | 3.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 0.6 | GO:0051324 | meiotic prophase I(GO:0007128) prophase(GO:0051324) meiotic cell cycle phase(GO:0098762) meiosis I cell cycle phase(GO:0098764) |
0.3 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 0.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 0.6 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.3 | 0.3 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
0.3 | 1.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.3 | 0.3 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.3 | 2.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.3 | 3.2 | GO:0015992 | proton transport(GO:0015992) |
0.3 | 19.7 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.3 | 3.9 | GO:0030177 | positive regulation of Wnt signaling pathway(GO:0030177) |
0.3 | 0.8 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.3 | 2.6 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.3 | 0.3 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.3 | 0.5 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.5 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 8.8 | GO:0006814 | sodium ion transport(GO:0006814) |
0.2 | 324.5 | GO:0007186 | G-protein coupled receptor signaling pathway(GO:0007186) |
0.2 | 12.5 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.2 | 3.3 | GO:0010827 | regulation of glucose transport(GO:0010827) |
0.2 | 0.2 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.2 | 0.2 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 6.3 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.5 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 2.5 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.2 | 2.2 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.2 | 1.5 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
0.2 | 0.4 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
0.2 | 0.4 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.2 | 0.4 | GO:0072663 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.2 | 0.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 3.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.2 | 0.6 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.2 | 0.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.4 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.2 | 5.9 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.2 | 0.4 | GO:0032511 | endosome transport via multivesicular body sorting pathway(GO:0032509) late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 0.4 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.2 | 0.8 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.2 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.2 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) establishment of RNA localization to telomere(GO:0097694) |
0.2 | 0.4 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.4 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.2 | 0.2 | GO:0060467 | negative regulation of fertilization(GO:0060467) prevention of polyspermy(GO:0060468) |
0.2 | 1.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
0.2 | 0.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 0.3 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.2 | 0.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 1.1 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 1.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 1.8 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 0.3 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 0.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 7.4 | GO:0098780 | mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
0.1 | 1.3 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.2 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 1.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 0.3 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 1.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.1 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.1 | 0.4 | GO:0032206 | positive regulation of telomere maintenance(GO:0032206) |
0.1 | 0.1 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 3.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 1.3 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 1.6 | GO:0050890 | cognition(GO:0050890) |
0.1 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 1.7 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
0.1 | 1.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.1 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) negative regulation of bone resorption(GO:0045779) |
0.1 | 0.2 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.1 | 1.1 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) |
0.1 | 0.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 0.1 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.1 | 7.5 | GO:0048232 | male gamete generation(GO:0048232) |
0.0 | 0.0 | GO:0051349 | positive regulation of lyase activity(GO:0051349) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.3 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.0 | 0.0 | GO:1903912 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.0 | 0.5 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
33.1 | 232.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
32.6 | 97.8 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
27.3 | 82.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
26.0 | 286.4 | GO:0043194 | axon initial segment(GO:0043194) |
24.6 | 221.0 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
24.2 | 290.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
23.5 | 117.3 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
21.8 | 130.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
21.5 | 42.9 | GO:0072686 | mitotic spindle(GO:0072686) |
21.2 | 84.7 | GO:0044308 | axonal spine(GO:0044308) |
20.1 | 603.6 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
19.6 | 19.6 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
19.5 | 19.5 | GO:0005883 | neurofilament(GO:0005883) |
18.9 | 18.9 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
18.9 | 151.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
18.0 | 53.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
17.8 | 71.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
17.8 | 213.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
17.8 | 124.3 | GO:0032584 | growth cone membrane(GO:0032584) |
17.5 | 333.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
17.2 | 103.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
16.8 | 704.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
16.4 | 16.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
16.3 | 49.0 | GO:0044393 | microspike(GO:0044393) |
15.9 | 398.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
15.9 | 63.7 | GO:0071953 | elastic fiber(GO:0071953) |
15.6 | 46.7 | GO:0072534 | perineuronal net(GO:0072534) |
15.0 | 15.0 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
14.9 | 89.4 | GO:0030673 | axolemma(GO:0030673) |
14.9 | 163.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
14.6 | 58.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
13.9 | 41.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
13.8 | 69.2 | GO:0043083 | synaptic cleft(GO:0043083) |
13.8 | 41.3 | GO:0000322 | storage vacuole(GO:0000322) |
13.7 | 41.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
13.2 | 185.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
13.2 | 765.3 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
13.1 | 13.1 | GO:0044299 | C-fiber(GO:0044299) |
12.8 | 12.8 | GO:0097427 | microtubule bundle(GO:0097427) |
12.8 | 294.1 | GO:0044295 | axonal growth cone(GO:0044295) |
12.7 | 50.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
12.5 | 37.6 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
12.1 | 437.0 | GO:0043198 | dendritic shaft(GO:0043198) |
11.9 | 107.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
11.9 | 106.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
11.7 | 23.4 | GO:0033268 | node of Ranvier(GO:0033268) |
11.6 | 116.2 | GO:0031527 | filopodium membrane(GO:0031527) |
11.5 | 34.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
11.4 | 170.6 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
10.9 | 32.8 | GO:1990393 | 3M complex(GO:1990393) |
10.9 | 10.9 | GO:0034705 | potassium channel complex(GO:0034705) |
10.9 | 1414.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
10.7 | 21.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
10.2 | 20.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
9.9 | 29.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
9.9 | 98.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
9.7 | 87.0 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
9.3 | 55.6 | GO:0097440 | apical dendrite(GO:0097440) |
9.2 | 806.5 | GO:0043204 | perikaryon(GO:0043204) |
9.1 | 45.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
9.1 | 91.1 | GO:0001527 | microfibril(GO:0001527) |
9.1 | 27.2 | GO:0048179 | activin receptor complex(GO:0048179) |
8.9 | 8.9 | GO:0043034 | costamere(GO:0043034) |
8.7 | 52.2 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
8.7 | 8.7 | GO:0035861 | site of double-strand break(GO:0035861) |
8.6 | 34.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
8.6 | 17.2 | GO:0044327 | dendritic spine head(GO:0044327) |
8.4 | 67.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
8.4 | 25.1 | GO:0097443 | sorting endosome(GO:0097443) |
8.2 | 32.8 | GO:0016342 | catenin complex(GO:0016342) |
8.1 | 24.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
7.9 | 87.3 | GO:0035102 | PRC1 complex(GO:0035102) |
7.8 | 116.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
7.7 | 100.0 | GO:0043679 | axon terminus(GO:0043679) |
7.7 | 107.4 | GO:0071565 | nBAF complex(GO:0071565) |
7.6 | 191.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
7.5 | 90.5 | GO:0031512 | motile primary cilium(GO:0031512) |
7.5 | 179.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
7.4 | 7.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
7.3 | 7.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
7.2 | 72.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
7.2 | 42.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
7.2 | 28.6 | GO:0097470 | ribbon synapse(GO:0097470) |
7.0 | 49.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
7.0 | 13.9 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
6.8 | 40.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
6.8 | 13.5 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
6.8 | 20.3 | GO:1990696 | USH2 complex(GO:1990696) |
6.8 | 527.4 | GO:0030426 | growth cone(GO:0030426) |
6.8 | 121.6 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
6.8 | 6.8 | GO:0097512 | cardiac myofibril(GO:0097512) |
6.6 | 132.3 | GO:0005922 | connexon complex(GO:0005922) |
6.5 | 45.8 | GO:0031143 | pseudopodium(GO:0031143) |
6.5 | 19.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
6.5 | 2108.4 | GO:0045202 | synapse(GO:0045202) |
6.5 | 26.0 | GO:0097433 | dense body(GO:0097433) |
6.4 | 51.4 | GO:0005861 | troponin complex(GO:0005861) |
6.4 | 12.7 | GO:0043511 | inhibin complex(GO:0043511) |
6.3 | 69.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
6.2 | 6.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
6.0 | 18.1 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
6.0 | 1612.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
6.0 | 41.8 | GO:0032433 | filopodium tip(GO:0032433) |
6.0 | 17.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
5.9 | 17.8 | GO:0034706 | sodium channel complex(GO:0034706) |
5.9 | 11.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
5.9 | 17.6 | GO:0042583 | chromaffin granule(GO:0042583) |
5.7 | 5.7 | GO:0031674 | I band(GO:0031674) |
5.6 | 22.3 | GO:0005915 | zonula adherens(GO:0005915) |
5.6 | 16.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
5.6 | 11.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
5.5 | 11.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
5.4 | 70.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
5.4 | 10.8 | GO:0043203 | axon hillock(GO:0043203) |
5.4 | 26.9 | GO:0033270 | paranode region of axon(GO:0033270) |
5.4 | 96.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
5.3 | 5.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
5.3 | 21.1 | GO:0061574 | ASAP complex(GO:0061574) |
5.2 | 10.3 | GO:0044297 | cell body(GO:0044297) |
5.1 | 15.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
5.0 | 40.3 | GO:0005921 | gap junction(GO:0005921) |
5.0 | 30.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
5.0 | 35.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
4.9 | 14.8 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
4.9 | 160.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
4.8 | 14.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
4.7 | 23.7 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
4.7 | 14.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
4.6 | 13.8 | GO:0005914 | spot adherens junction(GO:0005914) |
4.6 | 32.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
4.5 | 535.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
4.5 | 13.4 | GO:0043293 | apoptosome(GO:0043293) |
4.4 | 17.7 | GO:0000235 | astral microtubule(GO:0000235) |
4.4 | 8.7 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
4.3 | 4.3 | GO:0030286 | dynein complex(GO:0030286) |
4.3 | 133.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
4.3 | 1417.0 | GO:0043005 | neuron projection(GO:0043005) |
4.3 | 12.8 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
4.3 | 89.7 | GO:0034707 | chloride channel complex(GO:0034707) |
4.3 | 12.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
4.3 | 4.3 | GO:0035838 | growing cell tip(GO:0035838) |
4.2 | 93.2 | GO:0016235 | aggresome(GO:0016235) |
4.2 | 46.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
4.2 | 8.4 | GO:0070852 | cell body fiber(GO:0070852) |
4.2 | 95.7 | GO:0030315 | T-tubule(GO:0030315) |
4.1 | 20.7 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
4.1 | 20.5 | GO:0097255 | R2TP complex(GO:0097255) |
4.1 | 12.3 | GO:0033010 | paranodal junction(GO:0033010) |
4.1 | 12.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
4.1 | 4.1 | GO:0031252 | cell leading edge(GO:0031252) |
4.0 | 44.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
3.9 | 31.6 | GO:0036157 | outer dynein arm(GO:0036157) |
3.9 | 7.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
3.9 | 7.8 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
3.9 | 15.6 | GO:0070545 | PeBoW complex(GO:0070545) |
3.9 | 19.5 | GO:0071547 | piP-body(GO:0071547) |
3.9 | 11.6 | GO:0016589 | NURF complex(GO:0016589) |
3.8 | 3.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
3.8 | 11.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
3.7 | 25.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
3.7 | 33.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
3.7 | 18.4 | GO:0016460 | myosin II complex(GO:0016460) |
3.5 | 52.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
3.5 | 66.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
3.5 | 227.8 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
3.5 | 1146.7 | GO:0005667 | transcription factor complex(GO:0005667) |
3.4 | 3.4 | GO:0016600 | flotillin complex(GO:0016600) |
3.4 | 6.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
3.4 | 30.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
3.4 | 16.8 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
3.3 | 3.3 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
3.2 | 64.2 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
3.2 | 69.9 | GO:0030018 | Z disc(GO:0030018) |
3.1 | 9.3 | GO:0000802 | transverse filament(GO:0000802) |
3.1 | 214.4 | GO:0043296 | apical junction complex(GO:0043296) |
3.1 | 94.7 | GO:0005871 | kinesin complex(GO:0005871) |
3.1 | 33.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
3.0 | 27.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
3.0 | 30.4 | GO:0097225 | sperm midpiece(GO:0097225) |
3.0 | 24.3 | GO:0034451 | centriolar satellite(GO:0034451) |
3.0 | 9.1 | GO:0030139 | endocytic vesicle(GO:0030139) |
3.0 | 6.1 | GO:0097546 | ciliary base(GO:0097546) |
3.0 | 17.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
3.0 | 82.7 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
3.0 | 79.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
2.9 | 5.9 | GO:0032585 | multivesicular body membrane(GO:0032585) |
2.9 | 8.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
2.9 | 22.9 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
2.9 | 14.3 | GO:0042383 | sarcolemma(GO:0042383) |
2.9 | 17.1 | GO:0071439 | clathrin complex(GO:0071439) |
2.8 | 132.9 | GO:0031012 | extracellular matrix(GO:0031012) |
2.8 | 2.8 | GO:0097386 | glial cell projection(GO:0097386) |
2.8 | 8.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
2.8 | 8.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
2.8 | 13.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
2.7 | 11.0 | GO:0070695 | FHF complex(GO:0070695) |
2.7 | 19.1 | GO:0016272 | prefoldin complex(GO:0016272) |
2.7 | 13.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
2.7 | 10.9 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
2.7 | 21.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
2.7 | 5.4 | GO:0055037 | recycling endosome(GO:0055037) |
2.7 | 23.9 | GO:0030496 | midbody(GO:0030496) |
2.6 | 71.0 | GO:0005768 | endosome(GO:0005768) |
2.6 | 113.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
2.6 | 5.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
2.6 | 30.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
2.6 | 2.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
2.5 | 5.0 | GO:0097524 | sperm plasma membrane(GO:0097524) |
2.5 | 32.4 | GO:0036038 | MKS complex(GO:0036038) |
2.5 | 2.5 | GO:0032437 | cuticular plate(GO:0032437) |
2.5 | 22.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
2.5 | 7.4 | GO:1990357 | terminal web(GO:1990357) |
2.4 | 146.1 | GO:0097458 | neuron part(GO:0097458) |
2.4 | 136.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
2.4 | 2.4 | GO:0030891 | VCB complex(GO:0030891) |
2.4 | 9.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.4 | 14.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
2.4 | 9.6 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
2.4 | 2.4 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
2.4 | 2.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
2.4 | 14.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
2.3 | 7.0 | GO:0055087 | Ski complex(GO:0055087) |
2.3 | 326.5 | GO:0043235 | receptor complex(GO:0043235) |
2.3 | 20.9 | GO:0044453 | nuclear membrane part(GO:0044453) |
2.3 | 2.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
2.3 | 69.4 | GO:0005581 | collagen trimer(GO:0005581) |
2.3 | 6.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
2.3 | 9.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
2.3 | 4.6 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.3 | 9.1 | GO:0031209 | SCAR complex(GO:0031209) |
2.3 | 27.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
2.2 | 22.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
2.2 | 8.8 | GO:0071546 | pi-body(GO:0071546) |
2.2 | 8.8 | GO:1990745 | EARP complex(GO:1990745) |
2.2 | 6.5 | GO:0032806 | carboxy-terminal domain protein kinase complex(GO:0032806) |
2.2 | 8.7 | GO:0001652 | granular component(GO:0001652) |
2.2 | 8.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
2.2 | 53.9 | GO:0030027 | lamellipodium(GO:0030027) |
2.1 | 8.6 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
2.1 | 25.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
2.1 | 8.5 | GO:0072687 | meiotic spindle(GO:0072687) |
2.1 | 2.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
2.1 | 2.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.0 | 111.8 | GO:0005794 | Golgi apparatus(GO:0005794) |
2.0 | 145.3 | GO:0072372 | primary cilium(GO:0072372) |
2.0 | 20.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
2.0 | 4.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
2.0 | 9.8 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
2.0 | 13.7 | GO:0042587 | glycogen granule(GO:0042587) |
1.9 | 15.6 | GO:0034703 | cation channel complex(GO:0034703) |
1.9 | 5.8 | GO:0030662 | coated vesicle membrane(GO:0030662) |
1.9 | 22.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.9 | 9.4 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
1.9 | 16.7 | GO:0005694 | chromosome(GO:0005694) |
1.8 | 5.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
1.8 | 7.4 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.8 | 11.0 | GO:0031902 | late endosome membrane(GO:0031902) |
1.8 | 36.1 | GO:0016459 | myosin complex(GO:0016459) |
1.8 | 19.8 | GO:0030175 | filopodium(GO:0030175) |
1.8 | 5.4 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
1.8 | 12.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.8 | 1.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.8 | 19.7 | GO:0005903 | brush border(GO:0005903) |
1.8 | 1.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.7 | 15.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.7 | 20.9 | GO:0031201 | SNARE complex(GO:0031201) |
1.7 | 5.2 | GO:0042641 | actomyosin(GO:0042641) |
1.7 | 1.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.7 | 8.5 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.7 | 3.4 | GO:0061700 | GATOR2 complex(GO:0061700) |
1.7 | 10.1 | GO:0097228 | sperm principal piece(GO:0097228) |
1.7 | 10.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
1.7 | 1.7 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.7 | 6.7 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.7 | 34.7 | GO:0005844 | polysome(GO:0005844) |
1.6 | 31.3 | GO:0005839 | proteasome core complex(GO:0005839) |
1.6 | 11.5 | GO:0036379 | myofilament(GO:0036379) |
1.6 | 24.5 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.6 | 14.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
1.6 | 8.1 | GO:0045180 | basal cortex(GO:0045180) |
1.6 | 3.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.6 | 363.9 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
1.6 | 9.6 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
1.6 | 80.8 | GO:0098858 | actin-based cell projection(GO:0098858) |
1.6 | 129.5 | GO:0043209 | myelin sheath(GO:0043209) |
1.6 | 12.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.6 | 24.8 | GO:0036126 | sperm flagellum(GO:0036126) |
1.6 | 15.5 | GO:0005652 | nuclear lamina(GO:0005652) |
1.5 | 29.4 | GO:0005774 | vacuolar membrane(GO:0005774) |
1.5 | 23.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.5 | 57.2 | GO:0045095 | keratin filament(GO:0045095) |
1.5 | 10.8 | GO:0043232 | non-membrane-bounded organelle(GO:0043228) intracellular non-membrane-bounded organelle(GO:0043232) |
1.5 | 4.6 | GO:0031045 | dense core granule(GO:0031045) |
1.5 | 298.2 | GO:0070161 | anchoring junction(GO:0070161) |
1.5 | 6.0 | GO:0032021 | NELF complex(GO:0032021) |
1.5 | 3.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.5 | 4.4 | GO:0045178 | basal part of cell(GO:0045178) |
1.5 | 1.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
1.5 | 46.9 | GO:0098588 | bounding membrane of organelle(GO:0098588) |
1.5 | 5.8 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
1.4 | 10.1 | GO:0005776 | autophagosome(GO:0005776) |
1.4 | 7.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.4 | 5.5 | GO:0005770 | late endosome(GO:0005770) |
1.4 | 4.1 | GO:0002177 | manchette(GO:0002177) |
1.4 | 1.4 | GO:0034702 | ion channel complex(GO:0034702) |
1.4 | 4.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
1.4 | 37.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.4 | 5.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
1.4 | 5.4 | GO:0030016 | myofibril(GO:0030016) |
1.4 | 6.8 | GO:0030008 | TRAPP complex(GO:0030008) |
1.3 | 97.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
1.3 | 4.0 | GO:0036396 | MIS complex(GO:0036396) |
1.3 | 2.6 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
1.3 | 11.9 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.3 | 3.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.3 | 5.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
1.3 | 3.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.3 | 7.7 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
1.3 | 12.8 | GO:0005811 | lipid particle(GO:0005811) |
1.3 | 65.2 | GO:0005769 | early endosome(GO:0005769) |
1.3 | 5171.3 | GO:0016021 | integral component of membrane(GO:0016021) |
1.3 | 10.1 | GO:0045177 | apical part of cell(GO:0045177) |
1.3 | 94.4 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
1.2 | 41.9 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
1.2 | 14.6 | GO:0001726 | ruffle(GO:0001726) |
1.2 | 46.9 | GO:0005802 | trans-Golgi network(GO:0005802) |
1.2 | 105.5 | GO:0005929 | cilium(GO:0005929) |
1.1 | 5.7 | GO:0033391 | chromatoid body(GO:0033391) |
1.1 | 41.0 | GO:0042995 | cell projection(GO:0042995) |
1.1 | 8.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.1 | 5.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.1 | 10.6 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
1.0 | 4.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.0 | 4081.9 | GO:0005634 | nucleus(GO:0005634) |
1.0 | 13.2 | GO:0030904 | retromer complex(GO:0030904) |
1.0 | 1.0 | GO:0016234 | inclusion body(GO:0016234) |
1.0 | 37.9 | GO:0009986 | cell surface(GO:0009986) |
1.0 | 2.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
1.0 | 2.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.0 | 16.6 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
1.0 | 177.3 | GO:0005856 | cytoskeleton(GO:0005856) |
0.9 | 375.5 | GO:0005886 | plasma membrane(GO:0005886) |
0.9 | 41.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
0.9 | 0.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.9 | 97.7 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.9 | 5.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.8 | 2.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.8 | 180.5 | GO:0016020 | membrane(GO:0016020) |
0.8 | 1052.8 | GO:0005576 | extracellular region(GO:0005576) |
0.8 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.8 | 130.1 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.7 | 2.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.7 | 586.9 | GO:0005737 | cytoplasm(GO:0005737) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
39.7 | 198.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
34.6 | 103.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
33.7 | 134.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
33.2 | 99.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
31.9 | 31.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
31.8 | 95.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
31.2 | 93.7 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
28.5 | 85.4 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
28.4 | 113.7 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
28.2 | 141.2 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
27.5 | 55.0 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
27.3 | 109.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
26.7 | 160.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
25.3 | 278.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
25.0 | 75.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
25.0 | 25.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
24.8 | 74.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
24.7 | 98.8 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
23.1 | 69.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
23.0 | 92.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
22.1 | 243.4 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
21.5 | 171.9 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
21.5 | 64.4 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
21.4 | 21.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
20.0 | 20.0 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
19.9 | 99.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
19.8 | 59.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
19.4 | 77.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
18.5 | 55.4 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
18.4 | 55.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
18.2 | 145.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
18.2 | 109.1 | GO:0048495 | Roundabout binding(GO:0048495) |
17.8 | 53.4 | GO:0035939 | microsatellite binding(GO:0035939) |
17.3 | 86.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
16.5 | 132.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
16.3 | 81.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
16.2 | 64.8 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
15.7 | 62.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
15.6 | 78.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
15.6 | 46.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
15.6 | 62.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
15.6 | 62.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
15.5 | 155.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
15.5 | 77.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
15.5 | 108.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
15.3 | 153.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
14.9 | 74.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
14.8 | 74.2 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
14.6 | 14.6 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
14.6 | 58.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
14.6 | 43.9 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
14.6 | 101.9 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
14.5 | 334.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
14.5 | 275.4 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
14.5 | 333.0 | GO:0071837 | HMG box domain binding(GO:0071837) |
14.3 | 85.8 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
14.3 | 28.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
14.2 | 56.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
14.1 | 42.2 | GO:0070888 | E-box binding(GO:0070888) |
14.0 | 55.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
13.8 | 13.8 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
13.7 | 68.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
13.6 | 67.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
13.3 | 66.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
13.3 | 53.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
13.3 | 66.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
13.2 | 66.2 | GO:0070051 | fibrinogen binding(GO:0070051) |
13.1 | 52.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
13.1 | 65.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
13.0 | 143.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
13.0 | 117.3 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
13.0 | 39.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
13.0 | 116.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
12.9 | 141.6 | GO:0001972 | retinoic acid binding(GO:0001972) |
12.7 | 51.0 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
12.7 | 380.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
12.6 | 113.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
12.5 | 62.3 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
12.3 | 135.8 | GO:0042043 | neurexin family protein binding(GO:0042043) |
12.3 | 234.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
12.3 | 12.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
12.3 | 61.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
12.2 | 219.0 | GO:0005112 | Notch binding(GO:0005112) |
12.0 | 36.1 | GO:0018556 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
11.8 | 165.4 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
11.8 | 47.0 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
11.7 | 23.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
11.7 | 280.9 | GO:0046875 | ephrin receptor binding(GO:0046875) |
11.6 | 34.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
11.6 | 46.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
11.5 | 150.0 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
11.5 | 265.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
11.5 | 57.4 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
11.4 | 34.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
11.3 | 45.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
11.3 | 45.2 | GO:0097001 | ceramide binding(GO:0097001) |
11.3 | 56.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
11.3 | 350.1 | GO:0005109 | frizzled binding(GO:0005109) |
11.2 | 157.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
11.2 | 67.4 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
11.2 | 22.4 | GO:0051380 | norepinephrine binding(GO:0051380) |
11.1 | 33.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
11.0 | 132.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
10.9 | 10.9 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
10.8 | 215.2 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
10.8 | 118.3 | GO:0031005 | filamin binding(GO:0031005) |
10.7 | 32.0 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
10.7 | 42.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
10.6 | 21.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
10.5 | 31.6 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
10.5 | 73.5 | GO:0005272 | sodium channel activity(GO:0005272) |
10.5 | 10.5 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
10.5 | 104.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
10.3 | 30.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
10.3 | 92.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
10.2 | 20.4 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
10.1 | 202.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
9.9 | 49.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
9.7 | 29.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
9.7 | 29.1 | GO:0070052 | collagen V binding(GO:0070052) |
9.6 | 125.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
9.6 | 134.3 | GO:0015026 | coreceptor activity(GO:0015026) |
9.6 | 19.2 | GO:0008307 | structural constituent of muscle(GO:0008307) |
9.5 | 9.5 | GO:0038191 | neuropilin binding(GO:0038191) |
9.4 | 339.5 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
9.4 | 56.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
9.4 | 47.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
9.4 | 37.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
9.4 | 37.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
9.3 | 93.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
9.3 | 55.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
9.2 | 9.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
9.2 | 110.6 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
9.2 | 174.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
9.2 | 36.7 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
9.2 | 45.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
9.1 | 36.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
9.1 | 54.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
8.9 | 35.6 | GO:0004966 | galanin receptor activity(GO:0004966) |
8.9 | 8.9 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
8.9 | 8.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
8.8 | 96.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
8.7 | 121.4 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
8.6 | 17.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
8.6 | 34.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
8.6 | 51.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
8.5 | 264.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
8.5 | 25.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
8.5 | 59.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
8.4 | 16.9 | GO:0097016 | L27 domain binding(GO:0097016) |
8.4 | 25.3 | GO:0071253 | connexin binding(GO:0071253) |
8.4 | 25.3 | GO:0051373 | FATZ binding(GO:0051373) |
8.4 | 84.0 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
8.4 | 66.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
8.3 | 16.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
8.3 | 107.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
8.3 | 33.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
8.3 | 189.9 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
8.3 | 24.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
8.2 | 49.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
8.2 | 24.6 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
8.2 | 8.2 | GO:0001962 | alpha-1,3-galactosyltransferase activity(GO:0001962) |
8.2 | 32.6 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
8.1 | 40.7 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
8.1 | 8.1 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
8.1 | 16.2 | GO:0033265 | choline binding(GO:0033265) |
8.1 | 8.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
8.1 | 16.1 | GO:0034711 | inhibin binding(GO:0034711) |
8.0 | 40.1 | GO:0003680 | AT DNA binding(GO:0003680) |
8.0 | 39.9 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
7.9 | 39.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
7.8 | 218.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
7.7 | 38.4 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
7.7 | 23.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
7.6 | 98.7 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
7.6 | 38.0 | GO:0045545 | syndecan binding(GO:0045545) |
7.6 | 7.6 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
7.5 | 22.5 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
7.4 | 74.3 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
7.3 | 29.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
7.3 | 22.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
7.3 | 116.8 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
7.2 | 7.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
7.2 | 21.6 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
7.2 | 57.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
7.2 | 7.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
7.1 | 35.7 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
7.1 | 21.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
7.1 | 113.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
7.1 | 28.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
7.0 | 20.9 | GO:0031014 | troponin T binding(GO:0031014) |
6.9 | 6.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
6.8 | 129.5 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
6.8 | 115.9 | GO:0050699 | WW domain binding(GO:0050699) |
6.8 | 20.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
6.8 | 182.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
6.8 | 209.5 | GO:0022839 | ion gated channel activity(GO:0022839) |
6.8 | 13.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
6.7 | 268.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
6.7 | 33.4 | GO:0036122 | BMP binding(GO:0036122) |
6.6 | 26.5 | GO:1990254 | keratin filament binding(GO:1990254) |
6.6 | 19.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
6.6 | 78.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
6.6 | 13.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
6.5 | 6.5 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
6.5 | 194.3 | GO:0004629 | phospholipase C activity(GO:0004629) |
6.4 | 353.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
6.4 | 6.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
6.4 | 223.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
6.3 | 25.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
6.3 | 94.1 | GO:0051393 | alpha-actinin binding(GO:0051393) |
6.2 | 37.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
6.2 | 12.4 | GO:0042289 | MHC class II protein binding(GO:0042289) |
6.1 | 12.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
6.1 | 6.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
6.1 | 6.1 | GO:0015197 | peptide transporter activity(GO:0015197) |
6.1 | 24.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
6.1 | 60.7 | GO:0005522 | profilin binding(GO:0005522) |
6.0 | 12.1 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
6.0 | 12.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
6.0 | 36.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
5.9 | 23.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
5.9 | 17.7 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
5.9 | 17.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
5.9 | 64.7 | GO:0015643 | toxic substance binding(GO:0015643) |
5.9 | 11.7 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
5.8 | 40.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
5.8 | 23.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
5.8 | 233.4 | GO:0030276 | clathrin binding(GO:0030276) |
5.8 | 23.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
5.8 | 139.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
5.8 | 23.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
5.7 | 17.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
5.7 | 108.2 | GO:0003785 | actin monomer binding(GO:0003785) |
5.7 | 5.7 | GO:0048030 | disaccharide binding(GO:0048030) |
5.7 | 51.0 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
5.7 | 45.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
5.6 | 135.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
5.6 | 27.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
5.6 | 16.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
5.5 | 548.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
5.5 | 44.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
5.5 | 5.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
5.5 | 32.8 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
5.5 | 10.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
5.4 | 27.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
5.4 | 65.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
5.4 | 21.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
5.4 | 92.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
5.4 | 16.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
5.4 | 32.2 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
5.3 | 112.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
5.3 | 16.0 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
5.3 | 31.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
5.3 | 5.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
5.3 | 90.1 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
5.3 | 15.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
5.3 | 5.3 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
5.3 | 26.3 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
5.2 | 5.2 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
5.2 | 62.4 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
5.2 | 10.4 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
5.1 | 66.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
5.1 | 15.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
5.1 | 40.7 | GO:0030955 | potassium ion binding(GO:0030955) |
5.1 | 20.3 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
5.1 | 5.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
5.1 | 40.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
5.0 | 15.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
5.0 | 15.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
5.0 | 15.0 | GO:0008142 | oxysterol binding(GO:0008142) |
5.0 | 10.0 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
5.0 | 5.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
4.9 | 14.8 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
4.9 | 78.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
4.9 | 127.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
4.9 | 24.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
4.8 | 43.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
4.8 | 19.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
4.8 | 4.8 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
4.8 | 14.5 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
4.8 | 24.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
4.8 | 28.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
4.8 | 9.6 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
4.8 | 4.8 | GO:0050780 | dopamine receptor binding(GO:0050780) |
4.7 | 1032.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
4.7 | 127.8 | GO:0019894 | kinesin binding(GO:0019894) |
4.7 | 4.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
4.7 | 23.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
4.7 | 37.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
4.7 | 37.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
4.7 | 9.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
4.6 | 18.6 | GO:0044548 | S100 protein binding(GO:0044548) |
4.6 | 4.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
4.6 | 18.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
4.6 | 13.8 | GO:0035198 | miRNA binding(GO:0035198) |
4.6 | 36.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
4.6 | 9.2 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
4.6 | 27.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
4.6 | 22.9 | GO:0031419 | cobalamin binding(GO:0031419) |
4.6 | 36.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
4.5 | 13.6 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
4.5 | 9.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
4.5 | 45.3 | GO:0048038 | quinone binding(GO:0048038) |
4.5 | 13.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
4.5 | 9.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
4.5 | 36.1 | GO:0043274 | phospholipase binding(GO:0043274) |
4.5 | 221.2 | GO:0044325 | ion channel binding(GO:0044325) |
4.5 | 9.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
4.5 | 31.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
4.5 | 18.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
4.5 | 13.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
4.4 | 75.5 | GO:0031489 | myosin V binding(GO:0031489) |
4.4 | 22.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
4.4 | 4.4 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
4.4 | 43.6 | GO:0070064 | proline-rich region binding(GO:0070064) |
4.3 | 17.4 | GO:0045340 | mercury ion binding(GO:0045340) |
4.3 | 8.6 | GO:0043121 | neurotrophin binding(GO:0043121) |
4.3 | 4.3 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
4.3 | 4.3 | GO:0070840 | dynein complex binding(GO:0070840) |
4.3 | 8.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
4.3 | 38.4 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
4.3 | 17.0 | GO:0003840 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
4.3 | 12.8 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
4.2 | 21.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
4.2 | 21.1 | GO:0042805 | actinin binding(GO:0042805) |
4.2 | 25.1 | GO:0031432 | titin binding(GO:0031432) |
4.2 | 4.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
4.2 | 12.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
4.2 | 12.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
4.1 | 4.1 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
4.1 | 24.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
4.1 | 16.4 | GO:0071949 | FAD binding(GO:0071949) |
4.1 | 94.2 | GO:0017022 | myosin binding(GO:0017022) |
4.1 | 16.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
4.1 | 12.2 | GO:0055100 | adiponectin binding(GO:0055100) |
4.1 | 12.2 | GO:2001069 | glycogen binding(GO:2001069) |
4.0 | 16.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
4.0 | 4.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
4.0 | 12.0 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
4.0 | 43.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
4.0 | 1621.2 | GO:0005509 | calcium ion binding(GO:0005509) |
4.0 | 71.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
4.0 | 11.9 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
3.9 | 3.9 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
3.9 | 242.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
3.9 | 11.6 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
3.9 | 7.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
3.8 | 311.1 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
3.8 | 19.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
3.8 | 15.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
3.8 | 56.8 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
3.8 | 41.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
3.8 | 11.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
3.7 | 44.9 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
3.7 | 18.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
3.7 | 7.4 | GO:0043495 | protein anchor(GO:0043495) |
3.7 | 7.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
3.7 | 14.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
3.7 | 21.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
3.6 | 18.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
3.6 | 39.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
3.6 | 3.6 | GO:1990715 | mRNA CDS binding(GO:1990715) |
3.5 | 10.6 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
3.5 | 21.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
3.5 | 31.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
3.5 | 17.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
3.5 | 3.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
3.4 | 17.2 | GO:0030275 | LRR domain binding(GO:0030275) |
3.4 | 3.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
3.4 | 3.4 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
3.4 | 6.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
3.4 | 6.7 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
3.3 | 10.0 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
3.3 | 153.7 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
3.3 | 125.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
3.3 | 13.2 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
3.3 | 71.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
3.2 | 3.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
3.2 | 6.5 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
3.2 | 6.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
3.2 | 35.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
3.2 | 6.4 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
3.2 | 12.7 | GO:0001846 | opsonin binding(GO:0001846) |
3.2 | 57.0 | GO:0030332 | cyclin binding(GO:0030332) |
3.2 | 6.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
3.2 | 31.6 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
3.1 | 40.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
3.1 | 21.9 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
3.1 | 3.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
3.1 | 3.1 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
3.1 | 28.1 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
3.1 | 6.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
3.1 | 12.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
3.1 | 59.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
3.1 | 9.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
3.1 | 46.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
3.1 | 30.9 | GO:0070403 | NAD+ binding(GO:0070403) |
3.1 | 18.5 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
3.1 | 1841.3 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
3.1 | 6.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
3.0 | 9.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
3.0 | 39.5 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
3.0 | 3.0 | GO:0005119 | smoothened binding(GO:0005119) |
3.0 | 6.0 | GO:0050815 | phosphoserine binding(GO:0050815) |
3.0 | 29.9 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
3.0 | 8.9 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
3.0 | 8.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
3.0 | 11.8 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
2.9 | 2.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
2.9 | 5.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.9 | 148.4 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
2.9 | 46.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
2.9 | 49.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
2.8 | 2.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
2.8 | 2.8 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
2.8 | 8.4 | GO:0004103 | choline kinase activity(GO:0004103) |
2.8 | 14.0 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
2.8 | 8.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
2.8 | 36.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
2.8 | 2.8 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
2.8 | 2.8 | GO:0000403 | Y-form DNA binding(GO:0000403) |
2.8 | 33.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
2.8 | 16.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
2.7 | 8.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
2.7 | 2.7 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
2.7 | 89.1 | GO:0005254 | chloride channel activity(GO:0005254) |
2.7 | 2.7 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.7 | 5.4 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.7 | 37.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
2.7 | 34.8 | GO:0044654 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
2.7 | 5.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.7 | 114.0 | GO:0003777 | microtubule motor activity(GO:0003777) |
2.6 | 349.6 | GO:0015631 | tubulin binding(GO:0015631) |
2.6 | 7.9 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
2.6 | 21.0 | GO:0004017 | adenylate kinase activity(GO:0004017) |
2.6 | 28.7 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
2.6 | 10.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
2.6 | 2.6 | GO:0030172 | troponin C binding(GO:0030172) |
2.6 | 38.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
2.6 | 7.7 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
2.6 | 2.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
2.6 | 5.1 | GO:0043199 | sulfate binding(GO:0043199) |
2.6 | 2.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
2.6 | 12.8 | GO:0001968 | fibronectin binding(GO:0001968) |
2.5 | 7.6 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
2.5 | 53.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
2.5 | 10.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
2.5 | 27.9 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
2.5 | 7.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
2.5 | 7.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
2.5 | 15.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
2.5 | 22.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
2.5 | 7.5 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
2.5 | 7.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.5 | 14.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.5 | 12.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.5 | 12.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
2.5 | 4.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
2.5 | 29.6 | GO:0051183 | vitamin transporter activity(GO:0051183) |
2.5 | 4.9 | GO:0033192 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.5 | 7.4 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
2.5 | 27.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
2.4 | 7.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
2.4 | 14.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
2.4 | 63.1 | GO:0019838 | growth factor binding(GO:0019838) |
2.4 | 17.0 | GO:0018640 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
2.4 | 7.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
2.4 | 12.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
2.4 | 95.7 | GO:0003774 | motor activity(GO:0003774) |
2.4 | 59.6 | GO:0019798 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) procollagen-proline dioxygenase activity(GO:0019798) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
2.4 | 7.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
2.4 | 37.8 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
2.4 | 9.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
2.4 | 4.7 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
2.4 | 54.1 | GO:0008009 | chemokine activity(GO:0008009) |
2.3 | 11.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
2.3 | 58.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
2.3 | 25.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
2.3 | 9.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
2.3 | 20.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
2.3 | 6.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
2.3 | 11.4 | GO:0030371 | translation repressor activity(GO:0030371) |
2.3 | 9.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
2.2 | 2.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.2 | 4.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
2.2 | 6.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
2.2 | 6.7 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
2.2 | 2.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
2.2 | 233.9 | GO:0003729 | mRNA binding(GO:0003729) |
2.2 | 8.7 | GO:0004083 | bisphosphoglycerate 2-phosphatase activity(GO:0004083) |
2.2 | 17.4 | GO:0070694 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
2.2 | 63.1 | GO:0005518 | collagen binding(GO:0005518) |
2.1 | 4.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
2.1 | 14.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
2.1 | 12.7 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
2.1 | 4.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
2.1 | 8.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
2.1 | 4.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
2.1 | 2.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.1 | 6.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
2.1 | 29.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
2.1 | 2.1 | GO:0071209 | histone pre-mRNA DCP binding(GO:0071208) U7 snRNA binding(GO:0071209) |
2.0 | 4.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
2.0 | 63.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
2.0 | 6.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
2.0 | 6.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
2.0 | 12.0 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
2.0 | 2.0 | GO:0060589 | nucleoside-triphosphatase regulator activity(GO:0060589) |
2.0 | 7.9 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
2.0 | 2.0 | GO:0032052 | bile acid binding(GO:0032052) |
1.9 | 3.9 | GO:0030519 | snoRNP binding(GO:0030519) |
1.9 | 7.7 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.9 | 9.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
1.9 | 1.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
1.9 | 5.7 | GO:0022832 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
1.9 | 5.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.9 | 3.8 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
1.9 | 9.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
1.9 | 5.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.9 | 5.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
1.8 | 7.4 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.8 | 47.8 | GO:0051219 | phosphoprotein binding(GO:0051219) |
1.8 | 27.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
1.8 | 3.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
1.8 | 5.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.8 | 3.6 | GO:0008252 | nucleotidase activity(GO:0008252) |
1.8 | 1.8 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
1.8 | 14.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.8 | 19.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.8 | 1.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.8 | 5.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.8 | 19.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
1.8 | 1.8 | GO:0031402 | sodium ion binding(GO:0031402) |
1.8 | 8.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
1.8 | 28.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.8 | 3.5 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
1.8 | 3.5 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
1.8 | 5.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.7 | 26.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
1.7 | 107.6 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
1.7 | 19.0 | GO:0004672 | protein kinase activity(GO:0004672) |
1.7 | 13.7 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.7 | 1.7 | GO:0000009 | alpha-1,6-mannosyltransferase activity(GO:0000009) |
1.7 | 20.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
1.7 | 47.5 | GO:0043883 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
1.7 | 5.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
1.7 | 500.0 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
1.7 | 10.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.7 | 357.7 | GO:0008092 | cytoskeletal protein binding(GO:0008092) |
1.7 | 10.0 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
1.7 | 5.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
1.7 | 1.7 | GO:0016936 | galactoside binding(GO:0016936) |
1.7 | 8.3 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.7 | 1.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
1.6 | 3.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
1.6 | 6.5 | GO:0043842 | Kdo transferase activity(GO:0043842) |
1.6 | 1.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.6 | 3.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.6 | 4.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
1.6 | 9.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.6 | 4.7 | GO:0046030 | inositol trisphosphate phosphatase activity(GO:0046030) |
1.6 | 1.6 | GO:0034046 | poly(G) binding(GO:0034046) |
1.6 | 3.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
1.6 | 4.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
1.5 | 15.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
1.5 | 4.6 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.5 | 6.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
1.5 | 38.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
1.5 | 1.5 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
1.5 | 6.1 | GO:0003796 | lysozyme activity(GO:0003796) |
1.5 | 1.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.5 | 3.0 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
1.5 | 34.5 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
1.5 | 17.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.5 | 8.9 | GO:0070402 | NADPH binding(GO:0070402) |
1.5 | 2.9 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
1.5 | 30.8 | GO:0005262 | calcium channel activity(GO:0005262) |
1.5 | 13.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.4 | 18.8 | GO:0043621 | protein self-association(GO:0043621) |
1.4 | 12.9 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
1.4 | 57.0 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
1.4 | 5.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.4 | 5.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
1.4 | 4.2 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.4 | 8.4 | GO:0031490 | chromatin DNA binding(GO:0031490) |
1.4 | 2.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.4 | 11.1 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
1.4 | 13.9 | GO:0070628 | proteasome binding(GO:0070628) |
1.4 | 2.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.4 | 12.4 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.4 | 44.1 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
1.4 | 2.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
1.4 | 5.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
1.4 | 5.4 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.4 | 2.7 | GO:0008312 | 7S RNA binding(GO:0008312) |
1.3 | 4.0 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.3 | 9.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.3 | 2.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.3 | 1.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.3 | 2.6 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
1.3 | 3.9 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.3 | 5.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.3 | 2.6 | GO:0030546 | receptor activator activity(GO:0030546) |
1.3 | 2.6 | GO:0034061 | DNA polymerase activity(GO:0034061) |
1.3 | 1.3 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.3 | 6.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.3 | 6.4 | GO:0043955 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
1.3 | 2.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
1.3 | 3.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.3 | 52.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
1.2 | 7.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
1.2 | 1.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
1.2 | 3.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
1.2 | 6.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.2 | 1.2 | GO:0002046 | opsin binding(GO:0002046) |
1.2 | 6.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
1.2 | 6.1 | GO:0032183 | SUMO binding(GO:0032183) |
1.2 | 25.4 | GO:0005261 | cation channel activity(GO:0005261) |
1.2 | 49.5 | GO:0005516 | calmodulin binding(GO:0005516) |
1.2 | 33.8 | GO:0008237 | metallopeptidase activity(GO:0008237) |
1.2 | 2.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
1.2 | 4.7 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.2 | 23.7 | GO:0015297 | antiporter activity(GO:0015297) |
1.2 | 34.0 | GO:0002039 | p53 binding(GO:0002039) |
1.2 | 3.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.2 | 8.2 | GO:0004953 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) |
1.2 | 5.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.2 | 23.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.2 | 260.3 | GO:0005525 | GTP binding(GO:0005525) |
1.1 | 62.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
1.1 | 10.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
1.1 | 1.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.1 | 3.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
1.1 | 10.0 | GO:0030331 | estrogen receptor binding(GO:0030331) |
1.1 | 1.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
1.1 | 6.6 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
1.1 | 2.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.1 | 8.8 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 5.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
1.1 | 3.3 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
1.1 | 2.2 | GO:0070697 | activin receptor binding(GO:0070697) |
1.1 | 3.2 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.1 | 5.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
1.1 | 19.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
1.1 | 7.5 | GO:0005504 | fatty acid binding(GO:0005504) |
1.1 | 15.0 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
1.1 | 1.1 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
1.1 | 3.2 | GO:1990405 | protein antigen binding(GO:1990405) |
1.0 | 4.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
1.0 | 7.2 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.0 | 24.8 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
1.0 | 3.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
1.0 | 5.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.0 | 1.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
1.0 | 1.0 | GO:0070905 | serine binding(GO:0070905) |
1.0 | 34.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
1.0 | 5.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
1.0 | 4.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.0 | 6.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.0 | 1.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.0 | 1.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.9 | 64.4 | GO:0005179 | hormone activity(GO:0005179) |
0.9 | 151.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.9 | 72.5 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.9 | 0.9 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.9 | 8.1 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.9 | 2.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.9 | 0.9 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.9 | 5.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.9 | 7.1 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.9 | 0.9 | GO:0005534 | galactose binding(GO:0005534) |
0.9 | 229.1 | GO:0003677 | DNA binding(GO:0003677) |
0.9 | 9.6 | GO:0016247 | channel regulator activity(GO:0016247) |
0.9 | 3.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.9 | 8.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.9 | 3.5 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.9 | 0.9 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.9 | 5.2 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.9 | 5.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.8 | 343.1 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.8 | 5.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.8 | 2.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 63.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.8 | 6.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.8 | 2.5 | GO:0019003 | GDP binding(GO:0019003) |
0.8 | 0.8 | GO:0015927 | trehalase activity(GO:0015927) |
0.8 | 3.2 | GO:0015108 | chloride transmembrane transporter activity(GO:0015108) |
0.8 | 2.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.8 | 2.4 | GO:0004096 | catalase activity(GO:0004096) |
0.8 | 0.8 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.8 | 3.2 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.8 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.8 | 2.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.8 | 7.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.8 | 4.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.8 | 25.2 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.8 | 0.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.8 | 2.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.8 | 0.8 | GO:1901338 | catecholamine binding(GO:1901338) |
0.8 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.8 | 20.3 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.7 | 5.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.7 | 3.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.7 | 1.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.7 | 2.9 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.7 | 43.9 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.7 | 2.9 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.7 | 6.4 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.7 | 1.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.7 | 0.7 | GO:0019187 | beta-1,4-mannosyltransferase activity(GO:0019187) |
0.7 | 6.3 | GO:0005216 | ion channel activity(GO:0005216) |
0.7 | 4.2 | GO:0004386 | helicase activity(GO:0004386) |
0.7 | 2.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.7 | 13.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.7 | 2.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.7 | 2.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.7 | 6.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.7 | 0.7 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.7 | 94.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.7 | 1.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.7 | 5.3 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.7 | 94.8 | GO:0019904 | protein domain specific binding(GO:0019904) |
0.7 | 33.3 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.6 | 1.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.6 | 0.6 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.6 | 0.6 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.6 | 26.3 | GO:0008201 | heparin binding(GO:0008201) |
0.6 | 3.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.6 | 4.1 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.6 | 0.6 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.6 | 4.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.6 | 2.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.6 | 2.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.6 | 2.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 1.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.5 | 2.7 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.5 | 1.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.5 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.5 | 2.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.5 | 3.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 1.5 | GO:0035473 | lipase binding(GO:0035473) |
0.5 | 5.0 | GO:0001099 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.5 | 2.5 | GO:0045182 | translation regulator activity(GO:0045182) |
0.5 | 0.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.5 | 2.5 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.5 | 213.4 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.5 | 2.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.5 | 1.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.5 | 9.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.5 | 1.4 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.5 | 32.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.4 | 3.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 22.1 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 5.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 0.9 | GO:0060090 | binding, bridging(GO:0060090) |
0.4 | 0.9 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.4 | 3.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.4 | 0.4 | GO:0018586 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.4 | 0.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.4 | 5.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 3.4 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.4 | 1.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.4 | 6.7 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.4 | 1.8 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.7 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 6.9 | GO:0019905 | syntaxin binding(GO:0019905) |
0.3 | 2.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 58.5 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.3 | 3.0 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.3 | 0.3 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.3 | 1.1 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.3 | 2.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 0.3 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 1.5 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 0.5 | GO:0042562 | hormone binding(GO:0042562) |
0.2 | 18.9 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.2 | 0.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 3.4 | GO:0016853 | isomerase activity(GO:0016853) |
0.2 | 0.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.2 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.2 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.2 | 2.6 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.2 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 0.4 | GO:0005501 | retinoid binding(GO:0005501) |
0.2 | 3.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.2 | 1.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 47.5 | GO:0005198 | structural molecule activity(GO:0005198) |
0.2 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 0.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 3.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 329.2 | GO:0005515 | protein binding(GO:0005515) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 2.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.0 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 10.9 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.0 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.3 | 36.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
15.3 | 428.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
14.5 | 245.8 | PID EPHB FWD PATHWAY | EPHB forward signaling |
14.3 | 213.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
11.2 | 123.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
11.0 | 175.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
10.8 | 345.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
10.2 | 61.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
10.2 | 142.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
10.1 | 436.1 | NABA COLLAGENS | Genes encoding collagen proteins |
9.9 | 454.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
9.8 | 166.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
9.7 | 232.8 | PID REELIN PATHWAY | Reelin signaling pathway |
9.5 | 200.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
8.7 | 138.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
8.3 | 74.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
8.1 | 89.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
8.0 | 183.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
7.5 | 253.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
7.3 | 167.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
7.1 | 1220.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
7.0 | 140.1 | PID RAS PATHWAY | Regulation of Ras family activation |
6.9 | 13.9 | PID INSULIN PATHWAY | Insulin Pathway |
6.8 | 250.1 | PID BMP PATHWAY | BMP receptor signaling |
6.7 | 93.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
6.6 | 79.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
6.4 | 25.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
6.3 | 56.5 | PID S1P S1P4 PATHWAY | S1P4 pathway |
6.0 | 180.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
6.0 | 369.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
5.9 | 65.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
5.6 | 27.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
5.1 | 102.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
5.1 | 172.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
5.0 | 95.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
5.0 | 10.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
4.9 | 19.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
4.6 | 621.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
4.6 | 4.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
4.4 | 8.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
4.4 | 83.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
4.4 | 39.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
4.3 | 147.3 | PID NOTCH PATHWAY | Notch signaling pathway |
4.2 | 84.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
4.2 | 109.6 | PID FGF PATHWAY | FGF signaling pathway |
4.2 | 129.7 | PID LKB1 PATHWAY | LKB1 signaling events |
4.0 | 28.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
3.9 | 23.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
3.9 | 86.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
3.9 | 54.3 | PID ENDOTHELIN PATHWAY | Endothelins |
3.7 | 842.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
3.4 | 47.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
3.3 | 33.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
3.3 | 95.7 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
3.3 | 13.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
3.2 | 42.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
3.2 | 22.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.9 | 601.6 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
2.9 | 52.1 | PID CDC42 PATHWAY | CDC42 signaling events |
2.9 | 57.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
2.7 | 82.0 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
2.7 | 10.8 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
2.7 | 26.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
2.5 | 76.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
2.5 | 34.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
2.3 | 28.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
2.3 | 11.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.3 | 29.5 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
2.2 | 11.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
2.2 | 24.0 | PID ALK1 PATHWAY | ALK1 signaling events |
2.2 | 19.7 | PID ARF6 PATHWAY | Arf6 signaling events |
2.1 | 8.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
2.1 | 10.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
2.0 | 4.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
1.9 | 9.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.7 | 7.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.7 | 12.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
1.7 | 5.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.7 | 25.3 | PID ARF 3PATHWAY | Arf1 pathway |
1.6 | 34.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.6 | 28.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.6 | 20.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.5 | 27.8 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.5 | 7.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.4 | 14.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.3 | 35.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.0 | 4.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.9 | 6.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.9 | 16.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.9 | 14.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.8 | 4.2 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.8 | 7.9 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.7 | 17.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 11.9 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.7 | 10.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.7 | 0.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.7 | 5.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 7.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.6 | 1.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.5 | 4.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.5 | 5.6 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.5 | 5.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 7.1 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 0.3 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 5.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 7.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
30.2 | 30.2 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
25.8 | 25.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
21.6 | 324.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
20.2 | 20.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
19.6 | 235.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
18.9 | 189.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
18.0 | 252.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
18.0 | 252.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
17.2 | 188.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
15.3 | 658.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
15.0 | 583.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
14.4 | 86.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
14.1 | 141.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
14.1 | 449.9 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
13.6 | 54.4 | REACTOME GLYCOSAMINOGLYCAN METABOLISM | Genes involved in Glycosaminoglycan metabolism |
13.6 | 149.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
13.4 | 147.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
13.2 | 302.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
12.6 | 125.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
12.4 | 111.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
12.3 | 196.6 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
12.2 | 134.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
11.6 | 265.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
11.5 | 126.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
11.2 | 67.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
11.0 | 44.1 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
9.8 | 815.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
9.7 | 212.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
9.6 | 77.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
9.3 | 334.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
9.3 | 102.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
9.2 | 175.0 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
9.0 | 72.4 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
8.9 | 143.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
8.9 | 98.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
8.7 | 69.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
8.7 | 156.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
8.1 | 24.3 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
8.1 | 145.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
8.1 | 113.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
7.6 | 121.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
7.3 | 277.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
7.3 | 145.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
7.3 | 36.4 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
7.2 | 50.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
6.9 | 130.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
6.7 | 47.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
6.7 | 20.1 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
6.7 | 46.6 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
6.6 | 65.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
6.3 | 82.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
6.2 | 6.2 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
6.1 | 122.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
6.0 | 77.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
5.9 | 11.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
5.7 | 67.8 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
5.6 | 11.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
5.6 | 73.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
5.6 | 245.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
5.4 | 21.8 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
5.3 | 5.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
5.2 | 5.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
5.1 | 5.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
4.9 | 82.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
4.8 | 57.7 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
4.8 | 38.4 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
4.8 | 9.6 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
4.8 | 110.0 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
4.6 | 111.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
4.5 | 81.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
4.5 | 27.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
4.5 | 54.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
4.5 | 36.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
4.4 | 13.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
4.3 | 667.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
4.2 | 67.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
4.1 | 112.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
3.9 | 43.2 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
3.9 | 39.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
3.8 | 11.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
3.8 | 53.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
3.8 | 86.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
3.7 | 7.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
3.7 | 7.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
3.6 | 92.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
3.5 | 59.4 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
3.5 | 17.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
3.5 | 27.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
3.4 | 74.7 | REACTOME KINESINS | Genes involved in Kinesins |
3.4 | 3.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
3.3 | 13.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
3.3 | 19.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
3.2 | 29.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
3.2 | 121.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
3.2 | 60.5 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
3.1 | 31.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
3.1 | 15.6 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
3.1 | 18.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
3.1 | 21.5 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
3.0 | 3.0 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
3.0 | 50.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
2.8 | 8.5 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
2.8 | 30.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.8 | 2.8 | REACTOME OPSINS | Genes involved in Opsins |
2.8 | 11.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
2.8 | 2.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
2.7 | 18.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
2.7 | 37.7 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
2.6 | 38.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
2.5 | 2.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
2.4 | 59.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
2.3 | 23.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
2.3 | 53.7 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
2.3 | 36.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
2.3 | 15.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
2.3 | 38.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.3 | 15.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
2.2 | 44.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
2.2 | 56.1 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
2.1 | 17.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
2.1 | 16.8 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
2.1 | 20.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
2.1 | 26.9 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
2.0 | 51.0 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
2.0 | 81.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
2.0 | 4.0 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
2.0 | 16.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.0 | 2.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.9 | 27.0 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
1.9 | 7.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.9 | 42.9 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
1.8 | 5.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.8 | 5.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.7 | 15.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
1.7 | 6.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.7 | 5.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
1.5 | 6.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.5 | 16.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.5 | 17.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.4 | 30.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
1.4 | 5.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
1.4 | 14.0 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.4 | 15.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.4 | 15.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
1.3 | 59.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.3 | 5.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.3 | 3.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.2 | 14.1 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
1.1 | 7.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.1 | 6.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.1 | 17.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.1 | 2.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
1.1 | 30.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
1.1 | 3.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.0 | 39.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.0 | 1.0 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.9 | 7.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.9 | 8.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.9 | 11.1 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.9 | 6.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.9 | 7.2 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.9 | 22.9 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.8 | 1.7 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.8 | 2.5 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.8 | 33.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.8 | 48.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.8 | 7.6 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.7 | 43.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.7 | 3.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.7 | 6.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.6 | 0.6 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.6 | 8.0 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.6 | 1.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.6 | 15.7 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.6 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.5 | 5.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 15.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.5 | 6.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 38.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 12.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.5 | 7.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.4 | 1.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.4 | 5.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.4 | 0.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 3.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 0.8 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.4 | 2.6 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.4 | 8.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 6.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.3 | 1.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 6.5 | REACTOME MEMBRANE TRAFFICKING | Genes involved in Membrane Trafficking |
0.2 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 4.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.2 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.2 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.2 | 3.0 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 2.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.6 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 1.6 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 3.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.3 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |